1
|
Khalaf A, Lopez E, Li J, Horn A, Edlow BL, Blumenfeld H. Shared subcortical arousal systems across sensory modalities during transient modulation of attention. Neuroimage 2025; 312:121224. [PMID: 40250641 DOI: 10.1016/j.neuroimage.2025.121224] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2025] [Revised: 04/15/2025] [Accepted: 04/15/2025] [Indexed: 04/20/2025] Open
Abstract
Subcortical arousal systems are known to play a key role in controlling sustained changes in attention and conscious awareness. Recent studies indicate that these systems have a major influence on short-term dynamic modulation of visual attention, but their role across sensory modalities is not fully understood. In this study, we investigated shared subcortical arousal systems across sensory modalities during transient changes in attention using block and event-related fMRI paradigms. We analyzed massive publicly available fMRI datasets collected while 1561 participants performed visual, auditory, tactile, and taste perception tasks. Our analyses revealed a shared circuit of subcortical arousal systems exhibiting early transient increases in activity in midbrain reticular formation and central thalamus across perceptual modalities, as well as less consistent increases in pons, hypothalamus, basal forebrain, and basal ganglia. Identifying these networks is critical for understanding mechanisms of normal attention and consciousness and may help facilitate subcortical targeting for therapeutic neuromodulation.
Collapse
Affiliation(s)
- Aya Khalaf
- Department of Neurology, Yale University School of Medicine, New Haven, CT, USA
| | - Erick Lopez
- Department of Neurology, Yale University School of Medicine, New Haven, CT, USA
| | - Jian Li
- Department of Neurology, Center for Neurotechnology and Neurorecovery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA
| | - Andreas Horn
- Department of Neurology, Center for Neurotechnology and Neurorecovery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Department of Neurology, Center for Brain Circuit Therapeutics, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, USA; Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Movement Disorders & Neuromodulation Section, Department of Neurology, Charité - Universitätsmedizin, Berlin, Germany
| | - Brian L Edlow
- Department of Neurology, Center for Neurotechnology and Neurorecovery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA
| | - Hal Blumenfeld
- Department of Neurology, Yale University School of Medicine, New Haven, CT, USA; Department of Neuroscience, Yale University School of Medicine, New Haven, CT, USA; Department of Neurosurgery, Yale University School of Medicine, New Haven, CT, USA.
| |
Collapse
|
2
|
Yue Y, Tan Y, Yang P, Zhang S, Pan H, Lang Y, Yuan Z. Mapping Brain-Wide Neural Activity of Murine Attentional Processing in the Five-Choice Serial Reaction Time Task. Neurosci Bull 2025; 41:741-758. [PMID: 40121342 PMCID: PMC12014984 DOI: 10.1007/s12264-025-01380-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2024] [Accepted: 11/26/2024] [Indexed: 03/25/2025] Open
Abstract
Attention is the cornerstone of effective functioning in a complex and information-rich world. While the neural activity of attention has been extensively studied in the cortex, the brain-wide neural activity patterns are largely unknown. In this study, we conducted a comprehensive analysis of neural activity across the mouse brain during attentional processing using EEG and c-Fos staining, utilizing hierarchical clustering and c-Fos-based functional network analysis to evaluate the c-Fos activation patterns. Our findings reveal that a wide range of brain regions are activated, notably in the high-order cortex, thalamus, and brain stem regions involved in advanced cognition and arousal regulation, with the central lateral nucleus of the thalamus as a strong hub, suggesting the crucial role of the thalamus in attention control. These results provide valuable insights into the neural network mechanisms underlying attention, offering a foundation for formulating functional hypotheses and conducting circuit-level testing.
Collapse
Affiliation(s)
- Yin Yue
- The Brain Science Center, Beijing Institute of Basic Medical Sciences, Beijing, 100850, China.
| | - Youming Tan
- Hengyang Medical School, University of South China, Hengyang, 421001, China
| | - Pin Yang
- School of Basic Medical Sciences, Anhui Medical University, Hefei, 230022, China
| | - Shu Zhang
- School of Basic Medical Sciences, Anhui Medical University, Hefei, 230022, China
| | - Hongzhen Pan
- School of Medical Technology, Beijing Institute of Technology, Beijing, 100081, China
| | - Yiran Lang
- School of Medical Technology, Beijing Institute of Technology, Beijing, 100081, China.
| | - Zengqiang Yuan
- The Brain Science Center, Beijing Institute of Basic Medical Sciences, Beijing, 100850, China.
| |
Collapse
|
3
|
Attali D, Tiennot T, Manuel TJ, Daniel M, Houdouin A, Annic P, Dizeux A, Haroche A, Dadi G, Henensal A, Moyal M, Le Berre A, Paolillo C, Charron S, Debacker C, Lui M, Lekcir S, Mancusi R, Gallarda T, Sharshar T, Sylla K, Oppenheim C, Cachia A, Tanter M, Aubry JF, Plaze M. Deep transcranial ultrasound stimulation using personalized acoustic metamaterials improves treatment-resistant depression in humans. Brain Stimul 2025:S1935-861X(25)00099-3. [PMID: 40311843 DOI: 10.1016/j.brs.2025.04.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2024] [Revised: 04/17/2025] [Accepted: 04/26/2025] [Indexed: 05/03/2025] Open
Abstract
BACKGROUND Neuromodulation of deep brain regions has shown promise for treatment-resistant depression (TRD). However, it currently requires neurosurgical electrode implantation, posing significant risks and limiting widespread use while TRD affects around 100 million people worldwide. Low-intensity transcranial ultrasound stimulation (TUS) could allow precise and non-invasive deep neuromodulation, provided that the challenge of the defocusing effects of the skull is tackled. OBJECTIVE/HYPOTHESIS Here, we present the development of a portable and neuronavigated TUS prototype based on the use of patient-specific metamaterials (metalens) that correct for skull-induced aberrations. We then present the first application of metalens-based Transcranial Ultrasound Stimulation (mTUS) in TRD. The primary objective was to assess the safety and efficacy of mTUS targeting on individual level specific white matter tracts of the subcallosal cingulate involved in TRD. METHODS The safety and precision of this device was addressed through a series of numerical simulations and experimental measurements on ex vivo human skulls. Five participants with TRD were included in this open-label study (ClinicalTrials.gov identifier: NCT06085950) and underwent an intensive 5-day course of mTUS with a total of 25 sessions of 5 minutes each. RESULTS No serious adverse events occurred during the study. By day 5 of treatment, depression severity was reduced by an average of 60.9% (range: [30% - 83.9%]), and four out of five patients qualified as responders, with two of them in remission. CONCLUSIONS This study provides first-in-human evidence of the potential of mTUS as a precise, safe and effective non-invasive neuromodulation technique for neuropsychiatric disorders involving deep brain regions, offering a safer and more accessible alternative to invasive approaches.
Collapse
Affiliation(s)
- David Attali
- Institute Physics for Medicine Paris, Inserm U1273, ESPCI Paris, PSL University, CNRS UMR 8063, 75015 Paris, France; Department of Adult Psychiatry S17-18, GHU Paris Psychiatrie & Neurosciences, site Sainte-Anne, 75014 Paris, France; Department of Neuroanesthesiology and Intensive Care, GHU Paris Psychiatrie & Neurosciences, site Sainte-Anne, 75014 Paris, France
| | - Thomas Tiennot
- Institute Physics for Medicine Paris, Inserm U1273, ESPCI Paris, PSL University, CNRS UMR 8063, 75015 Paris, France
| | - Thomas J Manuel
- Institute Physics for Medicine Paris, Inserm U1273, ESPCI Paris, PSL University, CNRS UMR 8063, 75015 Paris, France
| | - Maxime Daniel
- Institute Physics for Medicine Paris, Inserm U1273, ESPCI Paris, PSL University, CNRS UMR 8063, 75015 Paris, France
| | - Alexandre Houdouin
- Institute Physics for Medicine Paris, Inserm U1273, ESPCI Paris, PSL University, CNRS UMR 8063, 75015 Paris, France
| | - Philippe Annic
- Institute Physics for Medicine Paris, Inserm U1273, ESPCI Paris, PSL University, CNRS UMR 8063, 75015 Paris, France
| | - Alexandre Dizeux
- Institute Physics for Medicine Paris, Inserm U1273, ESPCI Paris, PSL University, CNRS UMR 8063, 75015 Paris, France
| | - Alexandre Haroche
- Department of Adult Psychiatry S17-18, GHU Paris Psychiatrie & Neurosciences, site Sainte-Anne, 75014 Paris, France; Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, IMA-brain team, 75014 Paris, France
| | - Ghita Dadi
- Department of Adult Psychiatry S17-18, GHU Paris Psychiatrie & Neurosciences, site Sainte-Anne, 75014 Paris, France
| | - Adèle Henensal
- Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, IMA-brain team, 75014 Paris, France
| | - Mylène Moyal
- Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, IMA-brain team, 75014 Paris, France
| | - Alice Le Berre
- Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, IMA-brain team, 75014 Paris, France; Department of Neuroradiology, GHU Paris Psychiatrie & Neurosciences, site Sainte-Anne, 75014 Paris, France
| | - Cécile Paolillo
- Department of Adult Psychiatry S17-18, GHU Paris Psychiatrie & Neurosciences, site Sainte-Anne, 75014 Paris, France
| | - Sylvain Charron
- Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, IMA-brain team, 75014 Paris, France; Department of Neuroradiology, GHU Paris Psychiatrie & Neurosciences, site Sainte-Anne, 75014 Paris, France
| | - Clément Debacker
- Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, IMA-brain team, 75014 Paris, France; Department of Neuroradiology, GHU Paris Psychiatrie & Neurosciences, site Sainte-Anne, 75014 Paris, France
| | - Maliesse Lui
- Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, IMA-brain team, 75014 Paris, France; Department of Neuroradiology, GHU Paris Psychiatrie & Neurosciences, site Sainte-Anne, 75014 Paris, France
| | - Sabrina Lekcir
- Clinical Research and Innovation Department, GHU Paris Psychiatrie & Neurosciences, site Sainte-Anne, 75014 Paris, France
| | - Rosella Mancusi
- Clinical Research and Innovation Department, GHU Paris Psychiatrie & Neurosciences, site Sainte-Anne, 75014 Paris, France
| | - Thierry Gallarda
- Department of Adult Psychiatry S17-18, GHU Paris Psychiatrie & Neurosciences, site Sainte-Anne, 75014 Paris, France
| | - Tarek Sharshar
- Department of Neuroanesthesiology and Intensive Care, GHU Paris Psychiatrie & Neurosciences, site Sainte-Anne, 75014 Paris, France
| | - Khaoussou Sylla
- Clinical Research and Innovation Department, GHU Paris Psychiatrie & Neurosciences, site Sainte-Anne, 75014 Paris, France
| | - Catherine Oppenheim
- Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, IMA-brain team, 75014 Paris, France; Department of Neuroradiology, GHU Paris Psychiatrie & Neurosciences, site Sainte-Anne, 75014 Paris, France
| | - Arnaud Cachia
- Université Paris Cité, LaPsyDÉ, CNRS, F-75005, Paris, France; Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, IMA-brain team, 75014 Paris, France
| | - Mickael Tanter
- Institute Physics for Medicine Paris, Inserm U1273, ESPCI Paris, PSL University, CNRS UMR 8063, 75015 Paris, France
| | - Jean-Francois Aubry
- Institute Physics for Medicine Paris, Inserm U1273, ESPCI Paris, PSL University, CNRS UMR 8063, 75015 Paris, France.
| | - Marion Plaze
- Department of Adult Psychiatry S17-18, GHU Paris Psychiatrie & Neurosciences, site Sainte-Anne, 75014 Paris, France; Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, IMA-brain team, 75014 Paris, France
| |
Collapse
|
4
|
Pawlak WA, Howard N. Neuromorphic algorithms for brain implants: a review. Front Neurosci 2025; 19:1570104. [PMID: 40292025 PMCID: PMC12021827 DOI: 10.3389/fnins.2025.1570104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2025] [Accepted: 03/26/2025] [Indexed: 04/30/2025] Open
Abstract
Neuromorphic computing technologies are about to change modern computing, yet most work thus far has emphasized hardware development. This review focuses on the latest progress in algorithmic advances specifically for potential use in brain implants. We discuss current algorithms and emerging neurocomputational models that, when implemented on neuromorphic hardware, could match or surpass traditional methods in efficiency. Our aim is to inspire the creation and deployment of models that not only enhance computational performance for implants but also serve broader fields like medical diagnostics and robotics inspiring next generations of neural implants.
Collapse
|
5
|
Andrei D, Mederle AL, Ghenciu LA, Borza C, Faur AC. Efficacy of Neurorehabilitation Approaches in Traumatic Brain Injury Patients: A Comprehensive Review. Life (Basel) 2025; 15:503. [PMID: 40141847 PMCID: PMC11944267 DOI: 10.3390/life15030503] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2025] [Revised: 03/05/2025] [Accepted: 03/18/2025] [Indexed: 03/28/2025] Open
Abstract
Traumatic brain injury (TBI) represents a significant public health issue, causing long-term disabilities and imposing considerable socioeconomic and healthcare challenges. While advancements in acute care have improved survival rates, the demand for effective neurorehabilitation is increasing. This narrative review explores the evidence on neurorehabilitation strategies for TBI, focusing on interventions targeting cognitive, motor, and psychological recovery. A total of 32 studies were included and categorized into six approaches: non-invasive brain stimulation, virtual reality (VR), computer-based training, telerehabilitation, robot-assisted therapy (RAT), and mixed approaches. Non-invasive brain stimulation techniques, such as transcranial direct current stimulation (tDCS) and repetitive transcranial magnetic stimulation (rTMS), showed variable effectiveness in improving cognitive outcomes. VR-based therapies enhanced attention and executive functions, while RAT, such as Lokomat and exoskeletons, improved gait symmetry and functional mobility. Computer-assisted programs demonstrated benefits in rehabilitating social cognition and executive functions. Telerehabilitation and telephone-based treatments provided short-term gains but lacked sustained effects. Overall, cognitive improvements were better described and represented, while several motor improvements lacked consistency. Despite the promising results, significant gaps remain, including heterogeneity in methodologies, small sample sizes, and limited long-term outcome data.
Collapse
Affiliation(s)
- Diana Andrei
- Department XVI, Discipline of Medical Rehabilitation, University of Medicine and Pharmacy “Victor Babes”, 300041 Timisoara, Romania;
| | - Alexandra Laura Mederle
- Department XIV, Discipline of Dermatology, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania
| | - Laura Andreea Ghenciu
- Department III, Discipline of Pathophysiology, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania; (L.A.G.); (C.B.)
- Center for Translational Research and Systems Medicine, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania
| | - Claudia Borza
- Department III, Discipline of Pathophysiology, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania; (L.A.G.); (C.B.)
- Center for Translational Research and Systems Medicine, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania
- Centre of Cognitive Research in Pathological Neuro-Psychiatry NEUROPSY-COG, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania
| | - Alexandra Corina Faur
- Department I, Disciplone of Anatomy and Embriology, ‘Victor Babes’ University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania;
| |
Collapse
|
6
|
Marcuse LV, Langan M, Hof PR, Panov F, Saez I, Jimenez-Shahed J, Figee M, Mayberg H, Yoo JY, Ghatan S, Balchandani P, Fields MC. The thalamus: Structure, function, and neurotherapeutics. Neurotherapeutics 2025; 22:e00550. [PMID: 39956708 PMCID: PMC12014413 DOI: 10.1016/j.neurot.2025.e00550] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2024] [Revised: 01/28/2025] [Accepted: 02/03/2025] [Indexed: 02/18/2025] Open
Abstract
The complexity and expansive nature of thalamic research has led to numerous interventions for varied disease states. At the same time, this complexity along with siloed areas of study can hinder a comprehensive understanding. The goal of this paper is to give the reader a broader and more detailed perspective on the thalamus. In order to accomplish this goal, the paper begins with a summary of the function, electrophysiology, and anatomy of the normal thalamus. With this foundation, thalamic involvement in neurological diseases is discussed with a focus on epilepsy. Therapeutic interventions in the thalamus for epilepsy as well as movement disorders, psychiatric conditions and disorders of consciousness are described. Lastly limitations in the field and future models of data sharing and cooperation are explored.
Collapse
Affiliation(s)
- Lara V Marcuse
- Department of Neurology, Epilepsy Division, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1000 10th Ave, New York, NY 10019, USA.
| | - Mackenzie Langan
- BioMedical Engineering and Imaging Institute (BMEII), Icahn School of Medicine at Mount Sinai, 1470 Madison Ave, New York, NY 10029, USA
| | - Patrick R Hof
- Nash Family Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, 787 11th Avenue New York, NY 10019, USA
| | - Fedor Panov
- Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, 1000 10th Ave, New York, NY 10019, USA
| | - Igancio Saez
- Department of Neurology, Epilepsy Division, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1000 10th Ave, New York, NY 10019, USA; Nash Family Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, 787 11th Avenue New York, NY 10019, USA; Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, 1000 10th Ave, New York, NY 10019, USA; Nash Family Center for Advanced Circuit Therapeutics, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1000 10th Ave, New York, NY 10019, USA
| | - Joohi Jimenez-Shahed
- Department of Neurology, Movement Disorders Division, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1000 10th Ave, New York, NY 10019, USA
| | - Martijn Figee
- Department of Neurology, Movement Disorders Division, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1000 10th Ave, New York, NY 10019, USA
| | - Helen Mayberg
- Nash Family Center for Advanced Circuit Therapeutics, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1000 10th Ave, New York, NY 10019, USA
| | - Ji Yeoun Yoo
- Department of Neurology, Epilepsy Division, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1000 10th Ave, New York, NY 10019, USA
| | - Saadi Ghatan
- Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, 1000 10th Ave, New York, NY 10019, USA
| | - Priti Balchandani
- BioMedical Engineering and Imaging Institute (BMEII), Icahn School of Medicine at Mount Sinai, 1470 Madison Ave, New York, NY 10029, USA
| | - Madeline C Fields
- Department of Neurology, Epilepsy Division, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, 1000 10th Ave, New York, NY 10019, USA
| |
Collapse
|
7
|
Cao T, Chai X, Wu H, Wang N, Song J, He Q, Zhu S, Jia Y, Yang Y, Zhao J. Central Thalamic Deep Brain Stimulation Modulates Autonomic Nervous System Responsiveness in Disorders of Consciousness. CNS Neurosci Ther 2025; 31:e70274. [PMID: 40050126 PMCID: PMC11884924 DOI: 10.1111/cns.70274] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2024] [Revised: 01/15/2025] [Accepted: 01/31/2025] [Indexed: 03/10/2025] Open
Abstract
BACKGROUND The heart rate variability (HRV) of patients with disorders of consciousness (DOC) differs from healthy individuals. However, there is rarely research on HRV among DOC patients following treatment with deep brain stimulation (DBS). This study aims to investigate the modulatory effects of DBS-on the central-autonomic nervous system of DOC based on the study of HRV variations. METHODS We conducted DBS surgery on eight patients with DOC. Postoperatively, all patients underwent short-duration stimulation for 3 days, with stimulation frequencies of 25 Hz, 50 Hz, and 100 Hz respectively. Each day comprised four cycles, with a stimulation duration of 30 min DBS-on and 90 min DBS-off. We obtained the coma recovery scale-revised (CRS-R) scores and synchronously recorded electrocardiographic data. RESULITS We analyzed the HRV indices, including time-domain and frequency-domain parameters across various time points for all patients. The HRV exhibited a consistent trend across the three groups with different parameters. Notably, the most pronounced HRV changes were induced by the 100 Hz. Long-term follow-up indicates that high-frequency (HF), low-frequency (LF), and total power (TP) of HRV may serve as predictive indicators in the prognosis of patients. CONCLUSION Our study reveals that DBS enhances DOC patient consciousness while increasing HRV. Specifically, frequency-domain indices correlate with favorable prognosis.
Collapse
Affiliation(s)
- Tianqing Cao
- Department of Neurosurgery, Beijing Tiantan HospitalCapital Medical UniversityBeijingChina
- China National Clinical Research Center for Neurological DiseasesBeijingChina
| | - Xiaoke Chai
- Department of Neurosurgery, Beijing Tiantan HospitalCapital Medical UniversityBeijingChina
- China National Clinical Research Center for Neurological DiseasesBeijingChina
| | - Hongbin Wu
- Department of Neurosurgery, Beijing Tiantan HospitalCapital Medical UniversityBeijingChina
- China National Clinical Research Center for Neurological DiseasesBeijingChina
| | - Nan Wang
- Department of Neurosurgery, Beijing Tiantan HospitalCapital Medical UniversityBeijingChina
- China National Clinical Research Center for Neurological DiseasesBeijingChina
| | - Jiuxiang Song
- School of Advanced ManufacturingNanchang UniversityNanchangJiangxiChina
| | - Qiheng He
- Department of Neurosurgery, Beijing Tiantan HospitalCapital Medical UniversityBeijingChina
- China National Clinical Research Center for Neurological DiseasesBeijingChina
| | - Sipeng Zhu
- Department of Neurosurgery, Beijing Tiantan HospitalCapital Medical UniversityBeijingChina
- China National Clinical Research Center for Neurological DiseasesBeijingChina
| | - Yitong Jia
- Department of Neurosurgery, Beijing Tiantan HospitalCapital Medical UniversityBeijingChina
- China National Clinical Research Center for Neurological DiseasesBeijingChina
| | - Yi Yang
- Department of Neurosurgery, Beijing Tiantan HospitalCapital Medical UniversityBeijingChina
- China National Clinical Research Center for Neurological DiseasesBeijingChina
- Chinese Institute for Brain ResearchBeijingChina
- Beijing Institute of Brain DisordersBeijingChina
| | - Jizong Zhao
- Department of Neurosurgery, Beijing Tiantan HospitalCapital Medical UniversityBeijingChina
- China National Clinical Research Center for Neurological DiseasesBeijingChina
| |
Collapse
|
8
|
Gerber LM, Shulman KS, Wright MS, Schiff ND, Fins JJ. Qualitative Analysis of Symptoms from the Central Thalamic Deep Brain Stimulation Trial for Traumatic Brain Injury. NeuroRehabilitation 2025; 56:143-151. [PMID: 40260721 DOI: 10.1177/10538135241296732] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/24/2025]
Abstract
BackgroundStudies of moderate-to-severe traumatic brain injury (TBI) report persistent clinical impairment post-injury. In the CENTURY-S study of deep brain stimulation (DBS) in chronic TBI, Schiff et al.'s paper, "Thalamic deep brain stimulation in traumatic brain injury: a phase 1, randomized feasibility study" demonstrated improvements in executive control. A companion narrative analysis by Fins et al., "Subject and Family Perspectives from the Central Thalamic Deep Brain Stimulation Trial for Traumatic Brain Injury" Parts I and II described improvements in cognitive, behavioral, and emotional capabilities.ObjectiveThe present study provides an aggregate symptom assessment utilizing pre- and post-DBS narratives from subjects and their family members.MethodsDrawing upon participants from the CENTURY-S study, Fins et al. conducted semi-structured interviews with five subjects with moderate-to-severe TBI and their family members. Transcripts were subsequently coded deductively and inductively in Dedoose by two independent investigators.ResultsSubjects and families frequently volunteered memory and cognitive symptoms as well as difficulties with self-regulation, frustration, and irritability pre-DBS. Following stimulation, four subjects and four families noted improvement in memory and attention and focus, while three subjects and five families volunteered improvements in self-regulation. Fatigue improved in three subjects who previously reported this symptom and in one who did not.ConclusionsSecondary qualitative analysis of narrative data of DBS trial participants supports the incorporation of qualitative data as additional outcome measures in studies of DBS in TBI.
Collapse
Affiliation(s)
- Linda M Gerber
- Department of Population Health Sciences, Weill Cornell Medical College, NY, NY, USA
| | | | - Megan S Wright
- Division of Medical Ethics, Weill Cornell Medical College, NY, NY, USA
- College of Law, College of Medicine, Penn State University, University Park, PA, USA
| | - Nicholas D Schiff
- Feil Family Brain and Mind Research Institute, Weill Cornell Medical College, NY, NY, USA
| | - Joseph J Fins
- Division of Medical Ethics, Weill Cornell Medical College, NY, NY, USA
- Solomon Center for Health Law and Policy, Yale Law School, New Haven, CT, USA
| |
Collapse
|
9
|
Martinez-Nunez AE, Rozell CJ, Little S, Tan H, Schmidt SL, Grill WM, Pajic M, Turner DA, de Hemptinne C, Machado A, Schiff N, Holt-Becker AS, Raike RS, Malekmohammadi M, Pathak YJ, Himes L, Greene D, Krinke L, Arlotti M, Rossi L, Robinson J, Bahners BH, Litvak V, Milosevic L, Ghatan S, Schaper FLWVJ, Fox MD, Gregg NM, Kubu C, Jordano JJ, Cascella NG, Nho Y, Halpern CH, Mayberg HS, Choi KS, Song H, Cha J, Alagapan S, Dosenbach NUF, Gordon EM, Ren J, Liu H, Kalia LV, Kusyk D, Ramirez-Zamora A, Foote KD, Okun MS, Wong JK. Proceedings of the 12th annual deep brain stimulation think tank: cutting edge technology meets novel applications. Front Hum Neurosci 2025; 19:1544994. [PMID: 40070487 PMCID: PMC11893992 DOI: 10.3389/fnhum.2025.1544994] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2024] [Accepted: 02/06/2025] [Indexed: 03/14/2025] Open
Abstract
The Deep Brain Stimulation (DBS) Think Tank XII was held on August 21st to 23rd. This year we showcased groundbreaking advancements in neuromodulation technology, focusing heavily on the novel uses of existing technology as well as next-generation technology. Our keynote speaker shared the vision of using neuro artificial intelligence to predict depression using brain electrophysiology. Innovative applications are currently being explored in stroke, disorders of consciousness, and sleep, while established treatments for movement disorders like Parkinson's disease are being refined with adaptive stimulation. Neuromodulation is solidifying its role in treating psychiatric disorders such as depression and obsessive-compulsive disorder, particularly for patients with treatment-resistant symptoms. We estimate that 300,000 leads have been implanted to date for neurologic and neuropsychiatric indications. Magnetoencephalography has provided insights into the post-DBS physiological changes. The field is also critically examining the ethical implications of implants, considering the long-term impacts on clinicians, patients, and manufacturers.
Collapse
Affiliation(s)
| | - Christopher J. Rozell
- School of Electrical and Computer Engineering, Georgia Institute of Technology, Atlanta, GA, United States
| | - Simon Little
- Movement Disorders and Neuromodulation Centre, University of California San Francisco, San Francisco, CA, United States
| | - Huiling Tan
- Medical Research Council Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom
| | - Stephen L. Schmidt
- Departments of Biomedical Engineering, Electrical and Computer Engineering, Neurobiology and Neurosurgery, Duke University and Duke University Medical Center, Durham, NC, United States
| | - Warren M. Grill
- Departments of Biomedical Engineering, Electrical and Computer Engineering, Neurobiology and Neurosurgery, Duke University and Duke University Medical Center, Durham, NC, United States
- Department of Neurobiology, Duke University Medical Center, Durham, NC, United States
| | - Miroslav Pajic
- Departments of Biomedical Engineering, Electrical and Computer Engineering, Neurobiology and Neurosurgery, Duke University and Duke University Medical Center, Durham, NC, United States
| | - Dennis A. Turner
- Departments of Biomedical Engineering, Electrical and Computer Engineering, Neurobiology and Neurosurgery, Duke University and Duke University Medical Center, Durham, NC, United States
- Department of Neurobiology, Duke University Medical Center, Durham, NC, United States
- Department of Neurosurgery, Duke University Medical Center, Durham, NC, United States
| | - Coralie de Hemptinne
- Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL, United States
| | - Andre Machado
- Center for Neurological Restoration, Cleveland Clinic, Cleveland, OH, United States
- Department of Neurology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, United States
| | - Nicholas Schiff
- Weill Cornell Medical College, Feil Family Brain and Mind Research Institute, New York, NY, United States
| | - Abbey S. Holt-Becker
- Restorative Therapies Group Implantables, Research, and Core Technology, Medtronic Inc., Minneapolis, MN, United States
| | - Robert S. Raike
- Restorative Therapies Group Implantables, Research, and Core Technology, Medtronic Inc., Minneapolis, MN, United States
| | - Mahsa Malekmohammadi
- Department of Neurosurgery, University of California, Los Angeles, CA, United States
- Boston Scientific Neuromodulation, Valencia, CA, United States
| | | | - Lyndahl Himes
- Neuromodulation Division, Abbott, Plano, TX, United States
| | - David Greene
- NeuroPace, Inc., Mountain View, CA, United States
| | - Lothar Krinke
- Newronika SpA, Milan, Italy
- West Virginia University, Morgantown, WV, United States
| | | | | | - Jacob Robinson
- Department of Bioengineering, Rice University, Houston, TX, United States
- Department of Electrical and Computer Engineering, Rice University, Houston, TX, United States
| | - Bahne H. Bahners
- Department of Neurology, Brigham & Women's Hospital, Harvard Medical School, Center for Brain Circuit Therapeutics, Boston, MA, United States
- Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
- Department of Neurology, Center for Movement Disorders and Neuromodulation, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
| | - Vladimir Litvak
- Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, London, United Kingdom
| | - Luka Milosevic
- Clinical and Computational Neuroscience, Krembil Research Institute, University Health Network, Toronto, ON, Canada
- Faculty of Medicine, Institute for Neuromodulation and Neurotechnology, University Hospital Tübingen (UKT), University Tübingen, Tübingen, Germany
| | - Saadi Ghatan
- Department of Neurosurgery, Mount Sinai Medical Center, New York, NY, United States
- Department of Neurosurgery, Maria Fareri Children's Hospital, Westchester Medical Center, Valhalla, NY, United States
| | - Frederic L. W. V. J. Schaper
- Department of Neurology, Brigham & Women's Hospital, Harvard Medical School, Center for Brain Circuit Therapeutics, Boston, MA, United States
| | - Michael D. Fox
- Department of Neurology, Brigham & Women's Hospital, Harvard Medical School, Center for Brain Circuit Therapeutics, Boston, MA, United States
| | | | - Cynthia Kubu
- Center for Neurological Restoration, Cleveland Clinic, Cleveland, OH, United States
| | - James J. Jordano
- Department of Neurology, Georgetown University Medical Center, Washington, DC, United States
- Department of Biochemistry, Georgetown University Medical Center, Washington, DC, United States
- Neuroethics Studies Program, Georgetown University Medical Center, Washington, DC, United States
| | - Nicola G. Cascella
- Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, United States
| | - YoungHoon Nho
- Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA, United States
| | - Casey H. Halpern
- Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA, United States
- Department of Surgery, Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA, United States
| | - Helen S. Mayberg
- Nash Family Center for Advanced Circuit Therapeutics, Icahn School of Medicine at Mount Sinai, New York, NY, United States
- Department of Radiology and Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, United States
- Department of Neurology and Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Ki Sueng Choi
- Nash Family Center for Advanced Circuit Therapeutics, Icahn School of Medicine at Mount Sinai, New York, NY, United States
- Department of Radiology and Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Haneul Song
- Nash Family Center for Advanced Circuit Therapeutics, Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Jungho Cha
- Nash Family Center for Advanced Circuit Therapeutics, Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Sankar Alagapan
- School of Electrical and Computer Engineering, Georgia Institute of Technology, Atlanta, GA, United States
| | - Nico U. F. Dosenbach
- Department of Neurology, Washington University School of Medicine, St. Louis, MO, United States
- Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, United States
- Department of Psychological & Brain Sciences, Washington University, St. Louis, MO, United States
- Department of Biomedical Engineering, Washington University, St. Louis, MO, United States
- Program in Occupational Therapy, Washington University, St. Louis, MO, United States
- Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, United States
| | - Evan M. Gordon
- Department of Radiology, Washington University School of Medicine, St. Louis, MO, United States
| | | | - Hesheng Liu
- Changping Laboratory, Beijing, China
- Biomedical Pioneering Innovation Center, Peking University, Beijing, China
| | - Lorraine V. Kalia
- Edmond J Safra Program in Parkinson's Disease, Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto, ON, Canada
- Division of Neurology, Department of Medicine, University of Toronto, Toronto, ON, Canada
| | - Dorian Kusyk
- Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL, United States
| | - Adolfo Ramirez-Zamora
- Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL, United States
| | - Kelly D. Foote
- Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL, United States
| | - Michael S. Okun
- Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL, United States
| | - Joshua K. Wong
- Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL, United States
| |
Collapse
|
10
|
Jung Y, Mithani K, Suresh H, Warsi N, Harmsen IE, Breitbart S, Gorodetsky C, Fasano A, Fallah A, Hadjinicolaou A, Weil A, Ibrahim GM. Deep Brain Stimulation in Pediatric Populations: A Scoping Review of the Clinical Trial Landscape. Stereotact Funct Neurosurg 2025; 103:132-144. [PMID: 39756376 PMCID: PMC11965851 DOI: 10.1159/000543289] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2024] [Accepted: 11/19/2024] [Indexed: 01/07/2025]
Abstract
INTRODUCTION There has been rapid advancement in the development of deep brain stimulation (DBS) as a treatment option for adults for neurological and neuropsychiatric conditions. Here, we present a scoping review of completed and ongoing clinical trials focused on DBS in pediatric populations, highlighting key knowledge gaps. METHODS Three databases (PubMed, OVID, and Embase) and the clinicaltrials.gov registry were queried to identify clinical trials for DBS in pediatric cohorts (age ≤18 years). Prospective and retrospective case series were excluded. No restrictions were placed on the diagnoses or measured clinical outcomes. Individual patient demographics, diagnosis, DBS target, and primary endpoints were extracted and summarized. RESULTS A total of 13 clinical trials were included in the final review, consisting of 9 completed trials (357 screened) and 4 ongoing trials (82 screened). Of the completed trials, 6 studied dystonia (both inherited and acquired; participants aged 4-18 years) and 3 studied drug-resistant epilepsy (participants aged 4-17 years). Among the 6 trials for dystonia, 5 used the Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) as the primary endpoint. There were a total of 18 adverse events documented across 63 participants, with 5 of 9 studies reporting adverse events. Ongoing clinical trials are evaluating DBS for dystonia (N = 2), epilepsy (N = 1), and self-injurious behavior (N = 1). CONCLUSIONS This scoping review summarizes the landscape of clinical trials for DBS in children and youth. In dystonia, further research is warranted with more relevant pediatric outcome measures and for understudied patient subgroups and targets. There are also significant gaps in our understanding of evaluating the role of DBS in other neurological and neurodevelopmental disorders in pediatric populations. INTRODUCTION There has been rapid advancement in the development of deep brain stimulation (DBS) as a treatment option for adults for neurological and neuropsychiatric conditions. Here, we present a scoping review of completed and ongoing clinical trials focused on DBS in pediatric populations, highlighting key knowledge gaps. METHODS Three databases (PubMed, OVID, and Embase) and the clinicaltrials.gov registry were queried to identify clinical trials for DBS in pediatric cohorts (age ≤18 years). Prospective and retrospective case series were excluded. No restrictions were placed on the diagnoses or measured clinical outcomes. Individual patient demographics, diagnosis, DBS target, and primary endpoints were extracted and summarized. RESULTS A total of 13 clinical trials were included in the final review, consisting of 9 completed trials (357 screened) and 4 ongoing trials (82 screened). Of the completed trials, 6 studied dystonia (both inherited and acquired; participants aged 4-18 years) and 3 studied drug-resistant epilepsy (participants aged 4-17 years). Among the 6 trials for dystonia, 5 used the Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) as the primary endpoint. There were a total of 18 adverse events documented across 63 participants, with 5 of 9 studies reporting adverse events. Ongoing clinical trials are evaluating DBS for dystonia (N = 2), epilepsy (N = 1), and self-injurious behavior (N = 1). CONCLUSIONS This scoping review summarizes the landscape of clinical trials for DBS in children and youth. In dystonia, further research is warranted with more relevant pediatric outcome measures and for understudied patient subgroups and targets. There are also significant gaps in our understanding of evaluating the role of DBS in other neurological and neurodevelopmental disorders in pediatric populations.
Collapse
Affiliation(s)
- Youngkyung Jung
- Department of Neurosurgery, University of Toronto, Toronto, Ontario, Canada,
| | - Karim Mithani
- Department of Neurosurgery, University of Toronto, Toronto, Ontario, Canada
- Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada
- Division of Neurosurgery, Department of Surgery, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
| | - Hrishikesh Suresh
- Department of Neurosurgery, University of Toronto, Toronto, Ontario, Canada
- Division of Neurosurgery, Department of Surgery, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
- Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada
| | - Nebras Warsi
- Department of Neurosurgery, University of Toronto, Toronto, Ontario, Canada
- Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada
| | - Irene E Harmsen
- Division of Neurosurgery, University of Alberta, Edmonton, Alberta, Canada
| | - Sara Breitbart
- Department of Neurosurgery, University of Toronto, Toronto, Ontario, Canada
- Division of Neurology, Hospital for SickKids, Toronto, Ontario, Canada
| | - Carolina Gorodetsky
- Division of Neurology, Hospital for SickKids, Toronto, Ontario, Canada
- Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada
| | - Alfonso Fasano
- Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada
- Division of Neurology, Hospital for SickKids, Toronto, Ontario, Canada
- Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, Ontario, Canada
- Krembil Brain Institute, Toronto, Ontario, Canada
| | - Aria Fallah
- Department of Neurosurgery, David Geffen School of Medicine at University of California, Los Angeles, California, USA
| | | | - Alexander Weil
- Division of Neurosurgery, Department of Surgery, Sainte-Justine University Hospital Centre, Montreal, Québec, Canada
- Division of Neurosurgery, Department of Surgery, University of Montréal Hospital Centre (CHUM), Montreal, Québec, Canada
- Division of Neurology, Department of Pediatrics, Sainte-Justine University Hospital Centre, Montreal, Québec, Canada
| | - George M Ibrahim
- Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada
- Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada
- Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, Ontario, Canada
| |
Collapse
|
11
|
贺 威, 王 登, 孟 强, 何 峰, 许 敏, 明 东. [Applications and prospects of electroencephalography technology in neurorehabilitation assessment and treatment]. SHENG WU YI XUE GONG CHENG XUE ZA ZHI = JOURNAL OF BIOMEDICAL ENGINEERING = SHENGWU YIXUE GONGCHENGXUE ZAZHI 2024; 41:1271-1278. [PMID: 40000219 PMCID: PMC11955371 DOI: 10.7507/1001-5515.202404046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Received: 04/19/2024] [Revised: 10/14/2024] [Indexed: 02/27/2025]
Abstract
With the high incidence of neurological diseases such as stroke and mental illness, rehabilitation treatments for neurological disorders have received widespread attention. Electroencephalography (EEG) technology, despite its excellent temporal resolution, has historically been limited in application due to its insufficient spatial resolution, and is mainly confined to preoperative assessment, intraoperative monitoring, and epilepsy detection. However, traditional constraints of EEG technology are being overcome with the popularization of EEG technology with high-density over 64-lead, the application of innovative analysis techniques and the integration of multimodal techniques, which are significantly broadening its applications in clinical settings. These advancements have not only reinforced the irreplaceable role of EEG technology in neurorehabilitation assessment, but also expanded its therapeutic potential through its combined use with technologies such as transcranial magnetic stimulation, transcranial electrical stimulation and brain-computer interfaces. This article reviewed the applications, advancements, and future prospects of EEG technology in neurorehabilitation assessment and treatment. Advancements in technology and interdisciplinary collaboration are expected to drive new applications and innovations in EEG technology within the neurorehabilitation field, providing patients with more precise and personalized rehabilitation strategies.
Collapse
Affiliation(s)
- 威忠 贺
- 天津大学 医学工程与转化医学研究院(天津 300072)Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin 300072, P. R. China
| | - 登宇 王
- 天津大学 医学工程与转化医学研究院(天津 300072)Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin 300072, P. R. China
| | - 强帆 孟
- 天津大学 医学工程与转化医学研究院(天津 300072)Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin 300072, P. R. China
| | - 峰 何
- 天津大学 医学工程与转化医学研究院(天津 300072)Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin 300072, P. R. China
- 清华大学 医学院(北京 100084)School of Medicine, Tsinghua University, Beijing 100084, P. R. China
| | - 敏鹏 许
- 天津大学 医学工程与转化医学研究院(天津 300072)Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin 300072, P. R. China
- 清华大学 医学院(北京 100084)School of Medicine, Tsinghua University, Beijing 100084, P. R. China
| | - 东 明
- 天津大学 医学工程与转化医学研究院(天津 300072)Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin 300072, P. R. China
- 清华大学 医学院(北京 100084)School of Medicine, Tsinghua University, Beijing 100084, P. R. China
| |
Collapse
|
12
|
Yang Y, Cao TQ, He SH, Wang LC, He QH, Fan LZ, Huang YZ, Zhang HR, Wang Y, Dang YY, Wang N, Chai XK, Wang D, Jiang QH, Li XL, Liu C, Wang SY. Revolutionizing treatment for disorders of consciousness: a multidisciplinary review of advancements in deep brain stimulation. Mil Med Res 2024; 11:81. [PMID: 39690407 DOI: 10.1186/s40779-024-00585-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/25/2024] [Accepted: 11/26/2024] [Indexed: 12/19/2024] Open
Abstract
Among the existing research on the treatment of disorders of consciousness (DOC), deep brain stimulation (DBS) offers a highly promising therapeutic approach. This comprehensive review documents the historical development of DBS and its role in the treatment of DOC, tracing its progression from an experimental therapy to a detailed modulation approach based on the mesocircuit model hypothesis. The mesocircuit model hypothesis suggests that DOC arises from disruptions in a critical network of brain regions, providing a framework for refining DBS targets. We also discuss the multimodal approaches for assessing patients with DOC, encompassing clinical behavioral scales, electrophysiological assessment, and neuroimaging techniques methods. During the evolution of DOC therapy, the segmentation of central nuclei, the recording of single-neurons, and the analysis of local field potentials have emerged as favorable technical factors that enhance the efficacy of DBS treatment. Advances in computational models have also facilitated a deeper exploration of the neural dynamics associated with DOC, linking neuron-level dynamics with macroscopic behavioral changes. Despite showing promising outcomes, challenges remain in patient selection, precise target localization, and the determination of optimal stimulation parameters. Future research should focus on conducting large-scale controlled studies to delve into the pathophysiological mechanisms of DOC. It is imperative to further elucidate the precise modulatory effects of DBS on thalamo-cortical and cortico-cortical functional connectivity networks. Ultimately, by optimizing neuromodulation strategies, we aim to substantially enhance therapeutic outcomes and greatly expedite the process of consciousness recovery in patients.
Collapse
Affiliation(s)
- Yi Yang
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
- China National Clinical Research Center for Neurological Diseases, Beijing, 100070, China.
- Innovative Center, Beijing Institute of Brain Disorders, Beijing, 100070, China.
- Department of Neurosurgery, Chinese Institute for Brain Research, Beijing, 100070, China.
- Medical Research Council Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, OX3 7BN, UK.
| | - Tian-Qing Cao
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China
- China National Clinical Research Center for Neurological Diseases, Beijing, 100070, China
| | - Sheng-Hong He
- Medical Research Council Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, OX3 7BN, UK
| | - Lu-Chen Wang
- Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, 200433, China
| | - Qi-Heng He
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China
- China National Clinical Research Center for Neurological Diseases, Beijing, 100070, China
| | - Ling-Zhong Fan
- National Laboratory of Pattern Recognition, Institute of Automation, Chinese Academy of Sciences, Beijing, 100080, China
| | - Yong-Zhi Huang
- Institute of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, 300072, China
| | - Hao-Ran Zhang
- National Laboratory of Pattern Recognition, Institute of Automation, Chinese Academy of Sciences, Beijing, 100080, China
| | - Yong Wang
- State Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, 100080, China
| | - Yuan-Yuan Dang
- Department of Neurosurgery, Chinese PLA General Hospital, Beijing, 100080, China
| | - Nan Wang
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China
- China National Clinical Research Center for Neurological Diseases, Beijing, 100070, China
| | - Xiao-Ke Chai
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China
- China National Clinical Research Center for Neurological Diseases, Beijing, 100070, China
| | - Dong Wang
- Department of Neurosurgery, Ganzhou People's Hospital, Ganzhou, 341000, Jiangxi, China
| | - Qiu-Hua Jiang
- Department of Neurosurgery, Ganzhou People's Hospital, Ganzhou, 341000, Jiangxi, China
| | - Xiao-Li Li
- School of Automation Science and Engineering, South China University of Technology, Guangzhou, 510641, China
| | - Chen Liu
- School of Electrical and Information Engineering, Tianjin University, Tianjin, 300072, China.
| | - Shou-Yan Wang
- Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, 200433, China.
- School of Information Science and Technology, Fudan University, Shanghai, 200433, China.
| |
Collapse
|
13
|
Gorodetsky C, Mithani K, Breitbart S, Yan H, Zhang K, Gouveia FV, Warsi N, Suresh H, Wong SM, Huber J, Kerr EN, Kulkarni AV, Taylor MJ, P Hagopian L, Fasano A, Ibrahim GM. Deep Brain Stimulation of the Nucleus Accumbens for Severe Self-Injurious Behavior in Children: A Phase I Pilot Trial. Biol Psychiatry 2024:S0006-3223(24)01784-0. [PMID: 39645140 DOI: 10.1016/j.biopsych.2024.12.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/17/2024] [Revised: 10/26/2024] [Accepted: 12/02/2024] [Indexed: 12/09/2024]
Abstract
BACKGROUND Self-injurious behavior (SIB) consists of repetitive, nonaccidental movements that result in physical damage inflicted upon oneself, without suicidal intent. SIB is prevalent among children with autism spectrum disorder and can lead to permanent disability or death. Neuromodulation at a locus of neural circuitry implicated in SIB, the nucleus accumbens (NAc), may directly influence these behaviors. METHODS We completed a phase I, open-label clinical trial of deep brain stimulation (DBS) of the NAc in children with severe, treatment-refractory SIB (ClinicalTrials.gov identifier NCT03982888). Participants were monitored for 12 months following NAc-DBS to assess the primary outcomes of safety and feasibility. Secondary outcomes included serial assessments of SIB and SIB-associated behaviors, ambulatory actigraphy, and changes in brain glucose metabolism induced by DBS. RESULTS Six children (ages 7-14 years) underwent NAc-DBS without serious adverse events. One child was found to have a delayed asymptomatic intracranial hemorrhage adjacent to a DBS electrode that did not require intervention, and 3 children experienced transient worsening in irritability or SIB with titration of stimulation parameters. NAc-DBS resulted in significant reductions in SIB and SIB-associated behaviors across multiple standardized scales, concurrent with clinically meaningful improvements in quality of life. Ambulatory actigraphy showed reductions in high-amplitude limb movements and positron emission tomography revealed treatment-induced reductions in metabolic activity within the thalamus, striatum, and temporoinsular cortex. CONCLUSIONS This first-in-children phase 1 clinical trial demonstrates the safety and feasibility of NAc-DBS in children with severe, refractory SIB at high risk of physical injury and death and supports further investigations.
Collapse
Affiliation(s)
- Carolina Gorodetsky
- Division of Neurology, The Hospital for Sick Children, Toronto, Ontario, Canada
| | - Karim Mithani
- Division of Neurosurgery, The Hospital for Sick Children, Department of Surgery, University of Toronto, Toronto, Ontario, Canada; Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada
| | - Sara Breitbart
- Division of Neurosurgery, The Hospital for Sick Children, Department of Surgery, University of Toronto, Toronto, Ontario, Canada
| | - Han Yan
- Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada
| | - Kristina Zhang
- Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada
| | | | - Nebras Warsi
- Division of Neurosurgery, The Hospital for Sick Children, Department of Surgery, University of Toronto, Toronto, Ontario, Canada; Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada
| | - Hrishikesh Suresh
- Division of Neurosurgery, The Hospital for Sick Children, Department of Surgery, University of Toronto, Toronto, Ontario, Canada; Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada
| | - Simeon M Wong
- Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada
| | - Joelene Huber
- Division of Pediatric Medicine and Developmental Pediatrics, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
| | - Elizabeth N Kerr
- Department of Psychology, The Hospital for Sick Children, Toronto, Ontario, Canada
| | - Abhaya V Kulkarni
- Division of Neurosurgery, The Hospital for Sick Children, Department of Surgery, University of Toronto, Toronto, Ontario, Canada; Institute of Health Policy, Management & Evaluation, University of Toronto, Toronto, Ontario, Canada
| | - Margot J Taylor
- Program in Neuroscience and Mental Health, Hospital for Sick Children, Toronto, Ontario, Canada; Department of Psychology, The Hospital for Sick Children, Toronto, Ontario, Canada; Department of Diagnostic Imaging, Hospital for Sick Children, Toronto, Ontario, Canada
| | - Louis P Hagopian
- Neurobehavioral Unit, Department of Behavioural Psychology, Kennedy Krieger Institute, Baltimore, Maryland
| | - Alfonso Fasano
- Division of Neurology, The Hospital for Sick Children, Toronto, Ontario, Canada; Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada; Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Health Network, Krembil Brain Institute, Toronto, Ontario, Canada
| | - George M Ibrahim
- Division of Neurosurgery, The Hospital for Sick Children, Department of Surgery, University of Toronto, Toronto, Ontario, Canada; Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada; Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada; Program in Neuroscience and Mental Health, Hospital for Sick Children, Toronto, Ontario, Canada.
| |
Collapse
|
14
|
Segobin S, Haast RAM, Kumar VJ, Lella A, Alkemade A, Bach Cuadra M, Barbeau EJ, Felician O, Pergola G, Pitel AL, Saranathan M, Tourdias T, Hornberger M. A roadmap towards standardized neuroimaging approaches for human thalamic nuclei. Nat Rev Neurosci 2024; 25:792-808. [PMID: 39420114 DOI: 10.1038/s41583-024-00867-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/11/2024] [Indexed: 10/19/2024]
Abstract
The thalamus has a key role in mediating cortical-subcortical interactions but is often neglected in neuroimaging studies, which mostly focus on changes in cortical structure and activity. One of the main reasons for the thalamus being overlooked is that the delineation of individual thalamic nuclei via neuroimaging remains controversial. Indeed, neuroimaging atlases vary substantially regarding which thalamic nuclei are included and how their delineations were established. Here, we review current and emerging methods for thalamic nuclei segmentation in neuroimaging data and consider the limitations of existing techniques in terms of their research and clinical applicability. We address these challenges by proposing a roadmap to improve thalamic nuclei segmentation in human neuroimaging and, in turn, harmonize research approaches and advance clinical applications. We believe that a collective effort is required to achieve this. We hope that this will ultimately lead to the thalamic nuclei being regarded as key brain regions in their own right and not (as often currently assumed) as simply a gateway between cortical and subcortical regions.
Collapse
Affiliation(s)
- Shailendra Segobin
- Normandie University, UNICAEN, PSL Université Paris, EPHE, INSERM, U1077, CHU de Caen, Cyceron, Neuropsychologie et Imagerie de la Mémoire Humaine, Caen, France.
| | - Roy A M Haast
- Aix-Marseille University, CRMBM CNRS UMR 7339, Marseille, France
- APHM, La Timone Hospital, CEMEREM, Marseille, France
| | | | - Annalisa Lella
- Department of Translational Biomedicine and Neuroscience (DiBraiN), University of Bari Aldo Moro, Bari, Italy
| | - Anneke Alkemade
- Integrative Model-based Cognitive Neuroscience Unit, Department of Psychology, University of Amsterdam, Amsterdam, The Netherlands
| | - Meritxell Bach Cuadra
- CIBM Center for Biomedical Imaging, Lausanne, Switzerland
- Radiology Department, Lausanne University and University Hospital, Lausanne, Switzerland
| | - Emmanuel J Barbeau
- Centre de recherche Cerveau et Cognition (Cerco), UMR5549, CNRS - Université de Toulouse, Toulouse, France
| | - Olivier Felician
- Aix Marseille Université, INSERM INS UMR 1106, APHM, Marseille, France
| | - Giulio Pergola
- Department of Translational Biomedicine and Neuroscience (DiBraiN), University of Bari Aldo Moro, Bari, Italy
- Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA
- Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Anne-Lise Pitel
- Normandie University, UNICAEN, INSERM, U1237, PhIND "Physiopathology and Imaging of Neurological Disorders", NeuroPresage Team, Cyceron, Caen, France
| | | | - Thomas Tourdias
- Neuroimagerie diagnostique et thérapeutique, CHU de Bordeaux, Bordeaux, France
- Neurocentre Magendie, University of Bordeaux, INSERM U1215, Bordeaux, France
| | | |
Collapse
|
15
|
Snider SB, Gilmore N, Freeman HJ, Maffei C, Atalay A, Kumar RG, Li LM, Shi H, Bodien YG, Mac Donald CL, Dams-O’Connor K, Edlow BL. Cortical lesions and focal white matter injury are associated with attentional performance in chronic traumatic brain injury. Brain Commun 2024; 7:fcae420. [PMID: 39926612 PMCID: PMC11806419 DOI: 10.1093/braincomms/fcae420] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2024] [Revised: 10/16/2024] [Accepted: 11/20/2024] [Indexed: 02/11/2025] Open
Abstract
Cognitive impairment, often due to attentional deficits, is a primary driver of disability after traumatic brain injury. It remains unclear whether attentional deficits are caused by injury to specific brain structures or the total burden of injury. In this cross-sectional, multicentre cohort study, we tested whether the association between brain injury and attentional performance varies by neuroanatomic location. Participants in the late effects of traumatic brain injury study were at least 18 years old and at least 1 year after a mild, moderate or severe traumatic brain injury. They underwent MRI and neuropsychological assessment at one of two sites. The primary and secondary outcomes, each measuring aspects of attentional performance, were the Trails A t-score and the standardized score on California Verbal Learning Test 2 Immediate Recall Trial 1. Imaging variables included the size and location (seven regions and seven networks) of encephalomalacic brain lesions and regional white matter fractional anisotropy measured with diffusion MRI (14 regions). We used ANOVA to test whether attentional performance differed by lesion location and linear mixed models to test whether attentional performance differed based on regional fractional anisotropy. One hundred eighty-eight participants met inclusion criteria (mean age 57, 69% male, 88% White). Participants with encephalomalacic brain lesions [N = 73 (39%)] had worse Trails A [mean (95% confidence interval) difference: 4.7 (0.3, 9.1); P = 0.036] but not secondary outcome performance [-0.3 (-0.1, 0.7); P = 0.17]. Among participants with lesions, Trails A performance did not differ by lesion size (P = 0.07) or location (P = 0.41 by region; P = 0.78 by network). We identified a significant interaction between regional fractional anisotropy and attentional performance on both primary (P = 0.001) and secondary (P = 0.001) outcome measures. Post hoc testing identified the strongest associations with Trails A performance in the sagittal stratum [1 SD decrement in Trails A: -0.2 (-0.3, -0.1) SD change in fractional anisotropy; P Bonferroni = 0.0057] and external capsule [-0.1 (-0.2, -0.1); P Bonferroni = 0.042] and the strongest association with secondary attentional scores in the corpus callosum [0.2 (0.1, 0.3); P Bonferroni = 0.014]. In a multivariate model, white matter integrity in the sagittal stratum (P = 0.008), but not encephalomalacic lesions (P = 0.3), was independently associated with Trails A performance. Diminished white matter integrity and cortical injury were each associated with attentional test performance, but only white matter injury demonstrated independent and region-specific effects. The peak statistical association with attentional test performance was in the sagittal stratum, a widely connected white matter region. Further investigation into the connections spanning this and nearby regions may reveal therapeutic targets for neuromodulation.
Collapse
Affiliation(s)
- Samuel B Snider
- Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA
| | - Natalie Gilmore
- Center for Neurotechnology and Neurorecovery, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
| | - Holly J Freeman
- Center for Neurotechnology and Neurorecovery, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
| | - Chiara Maffei
- Center for Neurotechnology and Neurorecovery, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
- Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA
| | - Alexander Atalay
- Center for Neurotechnology and Neurorecovery, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
| | - Raj G Kumar
- Department of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
| | - Lucia M Li
- Department of Brain Sciences, Imperial College London, W12 0BZ London, UK
| | - Hui Shi
- Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA
| | - Yelena G Bodien
- Center for Neurotechnology and Neurorecovery, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
- Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital, Harvard Medical School, Charlestown, MA 02129, USA
| | | | - Kristen Dams-O’Connor
- Department of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
- Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
| | - Brian L Edlow
- Center for Neurotechnology and Neurorecovery, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
- Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA
| |
Collapse
|
16
|
Warren AEL, Raguž M, Friedrich H, Schaper FLWVJ, Tasserie J, Snider SB, Li J, Chua MMJ, Butenko K, Friedrich MU, Jha R, Iglesias JE, Carney PW, Fischer D, Fox MD, Boes AD, Edlow BL, Horn A, Chudy D, Rolston JD. A human brain network linked to restoration of consciousness after deep brain stimulation. MEDRXIV : THE PREPRINT SERVER FOR HEALTH SCIENCES 2024:2024.10.17.24314458. [PMID: 39484242 PMCID: PMC11527079 DOI: 10.1101/2024.10.17.24314458] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/03/2024]
Abstract
Disorders of consciousness (DoC) are states of impaired arousal or awareness. Deep brain stimulation (DBS) is a potential treatment, but outcomes vary, possibly due to differences in patient characteristics, electrode placement, or stimulation of specific brain networks. We studied 40 patients with DoC who underwent DBS targeting the thalamic centromedian-parafascicular complex. Better-preserved gray matter, especially in the striatum, correlated with consciousness improvement. Stimulation was most effective when electric fields extended into parafascicular and subparafascicular nuclei-ventral to the centromedian nucleus, near the midbrain-and when it engaged projection pathways of the ascending arousal network, including the hypothalamus, brainstem, and frontal lobe. Moreover, effective DBS sites were connected to networks similar to those underlying impaired consciousness due to generalized absence seizures and acquired lesions. These findings support the therapeutic potential of DBS for DoC, emphasizing the importance of precise targeting and revealing a broader link between effective DoC treatment and mechanisms underlying other conscciousness-impairing conditions.
Collapse
Affiliation(s)
- Aaron E L Warren
- Department of Neurosurgery, Mass General Brigham, Harvard Medical School, Boston, MA, USA
- Center for Brain Circuit Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Marina Raguž
- Department of Neurosurgery, Dubrava University Hospital, Zagreb, Croatia
- School of Medicine, Catholic University of Croatia, Zagreb, Croatia
| | - Helen Friedrich
- Center for Brain Circuit Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
- University of Wurzburg, Faculty of Medicine, Josef-Schneider-Str. 2, 97080, Wurzburg, Germany
| | - Frederic L W V J Schaper
- Center for Brain Circuit Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Jordy Tasserie
- Center for Brain Circuit Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Samuel B Snider
- Center for Brain Circuit Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Jian Li
- Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA
- Center for Neurotechnology and Neurorecovery, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Melissa M J Chua
- Department of Neurosurgery, Mass General Brigham, Harvard Medical School, Boston, MA, USA
- Center for Brain Circuit Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Konstantin Butenko
- Center for Brain Circuit Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Maximilian U Friedrich
- Center for Brain Circuit Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Rohan Jha
- Department of Neurosurgery, Mass General Brigham, Harvard Medical School, Boston, MA, USA
- Center for Brain Circuit Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Juan E Iglesias
- Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA
- Centre for Medical Image Computing, University College London, London, United Kingdom
- Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - Patrick W Carney
- Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia
- Florey Institute of Neuroscience and Mental Health, Heidelberg, Victoria, Australia
| | - David Fischer
- Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Michael D Fox
- Center for Brain Circuit Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Aaron D Boes
- Departments of Neurology, Pediatrics, and Psychiatry, Carver College of Medicine, University of Iowa, Iowa City, IA, USA
| | - Brian L Edlow
- Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA
- Center for Neurotechnology and Neurorecovery, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Andreas Horn
- Center for Brain Circuit Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Darko Chudy
- Department of Neurosurgery, Dubrava University Hospital, Zagreb, Croatia
- Department of Surgery, School of Medicine, University of Zagreb, Zagreb, Croatia
| | - John D Rolston
- Department of Neurosurgery, Mass General Brigham, Harvard Medical School, Boston, MA, USA
- Center for Brain Circuit Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| |
Collapse
|
17
|
Pfefferbaum A, Zahr NM, Sassoon SA, Fama R, Saranathan M, Pohl KM, Sullivan EV. Aging, HIV infection, and alcohol exert synergist effects on regional thalamic volumes resulting in functional impairment. Neuroimage Clin 2024; 44:103684. [PMID: 39423567 PMCID: PMC11513528 DOI: 10.1016/j.nicl.2024.103684] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2024] [Revised: 09/23/2024] [Accepted: 10/06/2024] [Indexed: 10/21/2024]
Abstract
OBJECTIVE Pharmacologically-treated people living with HIV infection have near-normal life spans with more than 50 % living into at-risk age for dementia and a disproportionate number relative to uninfected people engaging in unhealthy drinking. Accelerated aging in HIV occurs in some brain structures including the multinucleated thalamus. Unknown is whether aging with HIV affects thalamic nuclei and associated functions differentially and whether the common comorbidity of alcohol use disorder (AUD) + HIV accelerates aging. METHODS This mixed cross-sectional/longitudinal design examined 216 control, 69 HIV, and 74 HIV + AUD participants, age 25-75 years old at initial visit, examined 1-8 times. MRI thalamic volumetry, parcellated using THalamus Optimized Multi-Atlas Segmentation (THOMAS), identified 10 nuclei grouped into 4 functional regions for correlation with age and measures of neuropsychological, clinical, and hematological status. RESULTS Aging in the control group was best modeled with quadratic functions in the Anterior and Ventral regions and with linear functions in the Medial and Posterior regions. Relative to controls, age-related decline was even steeper in the Anterior and Ventral regions of the HIV group and in the Anterior region of the comorbid group. Anterior volumes of each HIV group declined significantly faster after age 50 (HIV = -2.4 %/year; HIV + AUD = -2.8 %/year) than that of controls (-1.8 %/year). Anterior and Ventral volumes were significantly smaller in the HIV + AUD than HIV-only group when controlling for infection factors. Although compared with controls HIV + AUD declined faster than HIV alone, the two HIV groups did not differ significantly from each other in aging rates. Declining Attention/Working Memory and Motor Skills performance correlated with Anterior and Posterior volume declines in the HIV + AUD group. CONCLUSIONS Regional thalamic volumetry detected normal aging declines, differential and accelerated volume losses in HIV, relations between age-related nuclear and performance declines, and exacerbation of volume declines in comorbid AUD contributing to functional deficits.
Collapse
Affiliation(s)
- Adolf Pfefferbaum
- Center for Health Sciences, SRI International, Menlo Park, CA, United States; Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, United States
| | - Natalie M Zahr
- Center for Health Sciences, SRI International, Menlo Park, CA, United States; Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, United States
| | - Stephanie A Sassoon
- Center for Health Sciences, SRI International, Menlo Park, CA, United States; Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, United States
| | - Rosemary Fama
- Center for Health Sciences, SRI International, Menlo Park, CA, United States; Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, United States
| | - Manojkumar Saranathan
- Department of Radiology, University of Massachusetts Chan School of Medicine, Worcester, MA, United States
| | - Kilian M Pohl
- Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, United States
| | - Edith V Sullivan
- Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, United States.
| |
Collapse
|
18
|
Jang H, Fotiadis P, Mashour GA, Hudetz AG, Huang Z. Thalamic Roles in Conscious Perception Revealed by Low-Intensity Focused Ultrasound Neuromodulation. BIORXIV : THE PREPRINT SERVER FOR BIOLOGY 2024:2024.10.07.617034. [PMID: 39416133 PMCID: PMC11483030 DOI: 10.1101/2024.10.07.617034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 10/19/2024]
Abstract
The neural basis of conscious perception remains incompletely understood. While cortical mechanisms of conscious content have been extensively investigated, the role of subcortical structures, including the thalamus, remains less explored. We aim to elucidate the causal contributions of different thalamic regions to conscious perception using transcranial low-intensity focused ultrasound (LIFU) neuromodulation. We hypothesize that modulating different thalamic regions would result in distinct perceptual outcomes. We apply LIFU in human volunteers to investigate region-specific and sonication parameter-dependent effects. We target anterior (transmodal-dominant) and posterior (unimodal-dominant) thalamic regions, further divided into ventral and dorsal regions, while participants perform a near-threshold visual perception task. Task performance is evaluated using Signal Detection Theory metrics. We find that the high duty cycle stimulation of the ventral anterior thalamus enhanced object recognition sensitivity. We also observe a general (i.e., region-independent) effect of LIFU on decision bias (i.e., a tendency toward a particular response) and object categorization accuracy. Specifically, high duty cycle stimulation decreases categorization accuracy, whereas low duty cycle shifts decision bias towards a more conservative stance. In conclusion, our results provide causal insight into the functional organization of the thalamus in shaping human visual experience and highlight the unique role of the transmodal-dominant ventral anterior thalamus.
Collapse
Affiliation(s)
- Hyunwoo Jang
- Neuroscience Graduate Program, University of Michigan, Ann Arbor, MI 48109, USA
- Center for Consciousness Science, University of Michigan Medical School, Ann Arbor, MI 48109, USA
| | - Panagiotis Fotiadis
- Center for Consciousness Science, University of Michigan Medical School, Ann Arbor, MI 48109, USA
- Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
| | - George A. Mashour
- Neuroscience Graduate Program, University of Michigan, Ann Arbor, MI 48109, USA
- Center for Consciousness Science, University of Michigan Medical School, Ann Arbor, MI 48109, USA
- Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
- Michigan Psychedelic Center, University of Michigan Medical School, Ann Arbor, MI, 48109, USA
- Department of Pharmacology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA
| | - Anthony G. Hudetz
- Neuroscience Graduate Program, University of Michigan, Ann Arbor, MI 48109, USA
- Center for Consciousness Science, University of Michigan Medical School, Ann Arbor, MI 48109, USA
- Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
- Michigan Psychedelic Center, University of Michigan Medical School, Ann Arbor, MI, 48109, USA
| | - Zirui Huang
- Neuroscience Graduate Program, University of Michigan, Ann Arbor, MI 48109, USA
- Center for Consciousness Science, University of Michigan Medical School, Ann Arbor, MI 48109, USA
- Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
- Michigan Psychedelic Center, University of Michigan Medical School, Ann Arbor, MI, 48109, USA
| |
Collapse
|
19
|
Khalaf A, Lopez E, Li J, Horn A, Edlow BL, Blumenfeld H. Shared subcortical arousal systems across sensory modalities during transient modulation of attention. BIORXIV : THE PREPRINT SERVER FOR BIOLOGY 2024:2024.09.16.613316. [PMID: 39345640 PMCID: PMC11429725 DOI: 10.1101/2024.09.16.613316] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 10/01/2024]
Abstract
Subcortical arousal systems are known to play a key role in controlling sustained changes in attention and conscious awareness. Recent studies indicate that these systems have a major influence on short-term dynamic modulation of visual attention, but their role across sensory modalities is not fully understood. In this study, we investigated shared subcortical arousal systems across sensory modalities during transient changes in attention using block and event-related fMRI paradigms. We analyzed massive publicly available fMRI datasets collected while 1,561 participants performed visual, auditory, tactile, and taste perception tasks. Our analyses revealed a shared circuit of subcortical arousal systems exhibiting early transient increases in activity in midbrain reticular formation and central thalamus across perceptual modalities, as well as less consistent increases in pons, hypothalamus, basal forebrain, and basal ganglia. Identifying these networks is critical for understanding mechanisms of normal attention and consciousness and may help facilitate subcortical targeting for therapeutic neuromodulation.
Collapse
Affiliation(s)
- Aya Khalaf
- Department of Neurology, Yale University School of Medicine, New Haven, CT, USA
| | - Erick Lopez
- Department of Neurology, Yale University School of Medicine, New Haven, CT, USA
| | - Jian Li
- Center for Neurotechnology and Neurorecovery, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA
| | - Andreas Horn
- Center for Neurotechnology and Neurorecovery, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- Center for Brain Circuit Therapeutics, Department of Neurology, Brigham & Women’s Hospital and Harvard Medical School, Boston, MA, USA
- Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- Movement Disorders & Neuromodulation Section, Department of Neurology, Charité – Universitätsmedizin, Berlin, Germany
| | - Brian L. Edlow
- Center for Neurotechnology and Neurorecovery, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA
| | - Hal Blumenfeld
- Department of Neurology, Yale University School of Medicine, New Haven, CT, USA
- Department of Neuroscience, Yale University School of Medicine, New Haven, CT, USA
- Department of Neurosurgery, Yale University School of Medicine, New Haven, CT, USA
| |
Collapse
|
20
|
Ho JC, Grigsby EM, Damiani A, Liang L, Balaguer JM, Kallakuri S, Tang LW, Barrios-Martinez J, Karapetyan V, Fields D, Gerszten PC, Hitchens TK, Constantine T, Adams GM, Crammond DJ, Capogrosso M, Gonzalez-Martinez JA, Pirondini E. Potentiation of cortico-spinal output via targeted electrical stimulation of the motor thalamus. Nat Commun 2024; 15:8461. [PMID: 39353911 PMCID: PMC11445460 DOI: 10.1038/s41467-024-52477-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2024] [Accepted: 09/05/2024] [Indexed: 10/03/2024] Open
Abstract
Cerebral white matter lesions prevent cortico-spinal descending inputs from effectively activating spinal motoneurons, leading to loss of motor control. However, in most cases, the damage to cortico-spinal axons is incomplete offering a potential target for therapies aimed at improving volitional muscle activation. Here we hypothesize that, by engaging direct excitatory connections to cortico-spinal motoneurons, stimulation of the motor thalamus could facilitate activation of surviving cortico-spinal fibers thereby immediately potentiating motor output. To test this hypothesis, we identify optimal thalamic targets and stimulation parameters that enhance upper-limb motor-evoked potentials and grip forces in anesthetized monkeys. This potentiation persists after white matter lesions. We replicate these results in humans during intra-operative testing. We then design a stimulation protocol that immediately improves strength and force control in a patient with a chronic white matter lesion. Our results show that electrical stimulation targeting surviving neural pathways can improve motor control after white matter lesions.
Collapse
Affiliation(s)
- Jonathan C Ho
- School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
- Rehab Neural Engineering Labs, University of Pittsburgh, Pittsburgh, PA, USA
| | - Erinn M Grigsby
- Rehab Neural Engineering Labs, University of Pittsburgh, Pittsburgh, PA, USA
- Department of Physical Medicine and Rehabilitation, University of Pittsburgh, Pittsburgh, PA, USA
| | - Arianna Damiani
- Rehab Neural Engineering Labs, University of Pittsburgh, Pittsburgh, PA, USA
- Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA
| | - Lucy Liang
- Rehab Neural Engineering Labs, University of Pittsburgh, Pittsburgh, PA, USA
- Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA
- Center for the Neural Basis of Cognition, Pittsburgh, PA, USA
| | - Josep-Maria Balaguer
- Rehab Neural Engineering Labs, University of Pittsburgh, Pittsburgh, PA, USA
- Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA
- Center for the Neural Basis of Cognition, Pittsburgh, PA, USA
| | - Sridula Kallakuri
- Rehab Neural Engineering Labs, University of Pittsburgh, Pittsburgh, PA, USA
- Department of Neuroscience, University of Pittsburgh, Pittsburgh, PA, USA
| | - Lilly W Tang
- School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
- Rehab Neural Engineering Labs, University of Pittsburgh, Pittsburgh, PA, USA
| | | | - Vahagn Karapetyan
- Rehab Neural Engineering Labs, University of Pittsburgh, Pittsburgh, PA, USA
- Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA
- Center for the Neural Basis of Cognition, Pittsburgh, PA, USA
| | - Daryl Fields
- Rehab Neural Engineering Labs, University of Pittsburgh, Pittsburgh, PA, USA
- Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, USA
| | - Peter C Gerszten
- Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, USA
| | - T Kevin Hitchens
- Department of Neurobiology, University of Pittsburgh, Pittsburgh, PA, USA
| | - Theodora Constantine
- Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, USA
| | - Gregory M Adams
- Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, USA
| | - Donald J Crammond
- Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, USA
| | - Marco Capogrosso
- Rehab Neural Engineering Labs, University of Pittsburgh, Pittsburgh, PA, USA
- Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA
- Center for the Neural Basis of Cognition, Pittsburgh, PA, USA
- Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, USA
| | - Jorge A Gonzalez-Martinez
- Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, USA
- Department of Neurobiology, University of Pittsburgh, Pittsburgh, PA, USA
| | - Elvira Pirondini
- Rehab Neural Engineering Labs, University of Pittsburgh, Pittsburgh, PA, USA.
- Department of Physical Medicine and Rehabilitation, University of Pittsburgh, Pittsburgh, PA, USA.
- Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA.
- Center for the Neural Basis of Cognition, Pittsburgh, PA, USA.
- University of Pittsburgh Clinical and Translational Science Institute (CTSI), Pittsburgh, PA, USA.
| |
Collapse
|
21
|
López LP, Coll-Andreu M, Torras-Garcia M, Font-Farré M, Oviedo GR, Capdevila L, Guerra-Balic M, Portell-Cortés I, Costa-Miserachs D, Morris TP. Aerobic exercise and cognitive function in chronic severe traumatic brain injury survivors: a within-subject A-B-A intervention study. BMC Sports Sci Med Rehabil 2024; 16:201. [PMID: 39334396 PMCID: PMC11438162 DOI: 10.1186/s13102-024-00993-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2024] [Accepted: 09/17/2024] [Indexed: 09/30/2024]
Abstract
BACKGROUND Following acute and sub-acute rehabilitation from severe traumatic brain injury (TBI), minimal to no efficacious interventions to treat ongoing cognitive deficits are available. Aerobic exercise is a non-invasive behavioral intervention with promise to treat cognitive deficits in TBI populations. METHODS Six individuals, aged 24-62 years, with chronic (> 8 months since injury) severe (Glasgow Coma Scale of 3-8) TBI were recruited from two outpatient rehabilitation centers. In an A-B-A study design, 20-weeks of supervised aerobic exercise interventions were delivered three times per week (phase B) in addition to participants typical rehabilitation schedules (phases A). The effect of phase B was tested on a trail making test part B (primary outcome measure of executive function) as well as objective daily physical activity (PA), using both group level (linear mixed effect models) and single subject statistics. RESULTS Five of six participants increased trail-making test part B by more than 10% pre-to-post phase B, with three of six making a clinically meaningful improvement (+ 1SD in normative scores). A significant main effect of time was seen with significant improvement in trail-making test part B pre-to-post exercise (phase B). No significant effects in other planned comparisons were found. Statistically significant increases in daily moderate-to-vigorous PA were also seen during phase B compared to phase A with three of six individuals making a significant behaviour change. CONCLUSIONS The addition of supervised aerobic exercise to typical rehabilitation strategies in chronic survivors of severe TBI can improve executive set shifting abilities and increase voluntary daily PA levels. TRIAL REGISTRATION Retrospective trial registration on July 11 2024 with trial number: ISRCTN17487462.
Collapse
Affiliation(s)
- Lidia Pérez López
- Department of Psychobiology and Methodology of Health Sciences, Institute of Neurosciences, Universitat Autònoma de Barcelona. Bellaterra (Cerdanyola del Vallès), Barcelona, Spain
| | - Margalida Coll-Andreu
- Department of Psychobiology and Methodology of Health Sciences, Institute of Neurosciences, Universitat Autònoma de Barcelona. Bellaterra (Cerdanyola del Vallès), Barcelona, Spain
| | - Meritxell Torras-Garcia
- Department of Psychobiology and Methodology of Health Sciences, Institute of Neurosciences, Universitat Autònoma de Barcelona. Bellaterra (Cerdanyola del Vallès), Barcelona, Spain
| | - Manel Font-Farré
- Department of Physical Activity and Sport Sciences, Faculty of Psychology, Education and Sport Sciences (FPCEE), University Ramon Llull, Císter 34, Barcelona, 08022, Spain
| | - Guillermo R Oviedo
- Department of Physical Activity and Sport Sciences, Faculty of Psychology, Education and Sport Sciences (FPCEE), University Ramon Llull, Císter 34, Barcelona, 08022, Spain
- Department of Kinesiology, Mississippi State University, Mississippi State, USA
| | - Lluis Capdevila
- Sport Research Institute, Autonomous University of Barcelona, Bellaterra (Cerdanyola del Vallès), Barcelona, Spain
| | - Myriam Guerra-Balic
- Department of Physical Activity and Sport Sciences, Faculty of Psychology, Education and Sport Sciences (FPCEE), University Ramon Llull, Císter 34, Barcelona, 08022, Spain
| | - Isabel Portell-Cortés
- Department of Psychobiology and Methodology of Health Sciences, Institute of Neurosciences, Universitat Autònoma de Barcelona. Bellaterra (Cerdanyola del Vallès), Barcelona, Spain
| | - David Costa-Miserachs
- Department of Psychobiology and Methodology of Health Sciences, Institute of Neurosciences, Universitat Autònoma de Barcelona. Bellaterra (Cerdanyola del Vallès), Barcelona, Spain
| | - Timothy P Morris
- Department of Physical Therapy, Movement and Rehabilitation Sciences, Northeastern University, 360 Huntington Avenue, Boston, MA, 02115, USA.
- Center for Cognitive and Brain Health, Northeastern University, 360 Huntington Avenue, Boston, MA, 02115, USA.
| |
Collapse
|
22
|
Pirondini E, Grigsby E, Tang L, Damiani A, Ho J, Montanaro I, Nouduri S, Trant S, Constantine T, Adams G, Franzese K, Mahon B, Fiez J, Crammond D, Stipancic K, Gonzalez-Martinez J. Targeted deep brain stimulation of the motor thalamus improves speech and swallowing motor functions after cerebral lesions. RESEARCH SQUARE 2024:rs.3.rs-5085807. [PMID: 39399682 PMCID: PMC11469375 DOI: 10.21203/rs.3.rs-5085807/v1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/15/2024]
Abstract
Speech and swallowing are complex motor acts that depend upon the integrity of input neural signals from motor cortical areas to control muscles of the head and neck. Lesions damaging these neural pathways result in weakness of key muscles causing dysarthria and dysphagia, leading to profound social isolation and risk of aspiration and suffocation. Here we show that Deep Brain Stimulation (DBS) of the motor thalamus improved speech and swallowing functions in two participants with dysarthria and dysphagia. First, we proved that DBS increased excitation of the face motor cortex, augmenting motor evoked potentials, and range and speed of motion of orofacial articulators in n = 10 volunteers with intact neural pathways. Then, we demonstrated that this potentiation led to immediate improvement in swallowing functions in a patient with moderate dysphagia and profound dysarthria as a consequence of a traumatic brain lesion. In this subject and in another with mild dysarthria, we showed that DBS immediately ameliorated impairments of respiratory, phonatory, resonatory, and articulatory control thus resulting in a clinically significant improvement in speech intelligibility. Our data provide first-in-human evidence that DBS can be used to treat dysphagia and dysarthria in people with cerebral lesions.
Collapse
|
23
|
Egawa S, Ader J, Claassen J. Recovery of consciousness after acute brain injury: a narrative review. J Intensive Care 2024; 12:37. [PMID: 39327599 PMCID: PMC11425956 DOI: 10.1186/s40560-024-00749-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2024] [Accepted: 09/01/2024] [Indexed: 09/28/2024] Open
Abstract
BACKGROUND Disorders of consciousness (DoC) are frequently encountered in both, acute and chronic brain injuries. In many countries, early withdrawal of life-sustaining treatments is common practice for these patients even though the accuracy of predicting recovery is debated and delayed recovery can be seen. In this review, we will discuss theoretical concepts of consciousness and pathophysiology, explore effective strategies for management, and discuss the accurate prediction of long-term clinical outcomes. We will also address research challenges. MAIN TEXT DoC are characterized by alterations in arousal and/or content, being classified as coma, unresponsive wakefulness syndrome/vegetative state, minimally conscious state, and confusional state. Patients with willful modulation of brain activity detectable by functional MRI or EEG but not by behavioral examination is a state also known as covert consciousness or cognitive motor dissociation. This state may be as common as every 4th or 5th patient without behavioral evidence of verbal command following and has been identified as an independent predictor of long-term functional recovery. Underlying mechanisms are uncertain but intact arousal and thalamocortical projections maybe be essential. Insights into the mechanisms underlying DoC will be of major importance as these will provide a framework to conceptualize treatment approaches, including medical, mechanical, or electoral brain stimulation. CONCLUSIONS We are beginning to gain insights into the underlying mechanisms of DoC, identifying novel advanced prognostication tools to improve the accuracy of recovery predictions, and are starting to conceptualize targeted treatments to support the recovery of DoC patients. It is essential to determine how these advancements can be implemented and benefit DoC patients across a range of clinical settings and global societal systems. The Curing Coma Campaign has highlighted major gaps knowledge and provides a roadmap to advance the field of coma science with the goal to support the recovery of patients with DoC.
Collapse
Affiliation(s)
- Satoshi Egawa
- Department of Neurology, Neurological Institute, Columbia University Medical Center, NewYork-Presbyterian Hospital, 177 Fort Washington Avenue, MHB 8 Center, Room 300, New York, NY, 10032, USA
- NewYork-Presbyterian Hospital, New York, NY, USA
| | - Jeremy Ader
- Department of Neurology, Neurological Institute, Columbia University Medical Center, NewYork-Presbyterian Hospital, 177 Fort Washington Avenue, MHB 8 Center, Room 300, New York, NY, 10032, USA
- NewYork-Presbyterian Hospital, New York, NY, USA
| | - Jan Claassen
- Department of Neurology, Neurological Institute, Columbia University Medical Center, NewYork-Presbyterian Hospital, 177 Fort Washington Avenue, MHB 8 Center, Room 300, New York, NY, 10032, USA.
- NewYork-Presbyterian Hospital, New York, NY, USA.
| |
Collapse
|
24
|
Huang Z, Mashour GA, Hudetz AG. Propofol disrupts the functional core-matrix architecture of the thalamus in humans. Nat Commun 2024; 15:7496. [PMID: 39251579 PMCID: PMC11384736 DOI: 10.1038/s41467-024-51837-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2024] [Accepted: 08/15/2024] [Indexed: 09/11/2024] Open
Abstract
Research into the role of thalamocortical circuits in anesthesia-induced unconsciousness is difficult due to anatomical and functional complexity. Prior neuroimaging studies have examined either the thalamus as a whole or focused on specific subregions, overlooking the distinct neuronal subtypes like core and matrix cells. We conducted a study of heathy volunteers and functional magnetic resonance imaging during conscious baseline, deep sedation, and recovery. We advanced the functional gradient mapping technique to delineate the functional geometry of thalamocortical circuits, within a framework of the unimodal-transmodal functional axis of the cortex. Here we show a significant shift in this geometry during deep sedation, marked by a transmodal-deficient geometry. This alteration is closely linked to the spatial variations in the matrix cell composition within the thalamus. This research bridges cellular and systems-level understanding, highlighting the crucial role of thalamic core-matrix functional architecture in understanding the neural mechanisms of states of consciousness.
Collapse
Affiliation(s)
- Zirui Huang
- Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, MI, USA.
- Center for Consciousness Science, University of Michigan Medical School, Ann Arbor, MI, USA.
- Michigan Psychedelic Center, University of Michigan Medical School, Ann Arbor, MI, USA.
- Neuroscience Graduate Program, University of Michigan, Ann Arbor, MI, USA.
| | - George A Mashour
- Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, MI, USA
- Center for Consciousness Science, University of Michigan Medical School, Ann Arbor, MI, USA
- Michigan Psychedelic Center, University of Michigan Medical School, Ann Arbor, MI, USA
- Neuroscience Graduate Program, University of Michigan, Ann Arbor, MI, USA
- Department of Pharmacology, University of Michigan Medical School, Ann Arbor, MI, USA
| | - Anthony G Hudetz
- Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, MI, USA
- Center for Consciousness Science, University of Michigan Medical School, Ann Arbor, MI, USA
- Michigan Psychedelic Center, University of Michigan Medical School, Ann Arbor, MI, USA
- Neuroscience Graduate Program, University of Michigan, Ann Arbor, MI, USA
| |
Collapse
|
25
|
Hadar PN, Zelmann R, Salami P, Cash SS, Paulk AC. The Neurostimulationist will see you now: prescribing direct electrical stimulation therapies for the human brain in epilepsy and beyond. Front Hum Neurosci 2024; 18:1439541. [PMID: 39296917 PMCID: PMC11408201 DOI: 10.3389/fnhum.2024.1439541] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2024] [Accepted: 08/23/2024] [Indexed: 09/21/2024] Open
Abstract
As the pace of research in implantable neurotechnology increases, it is important to take a step back and see if the promise lives up to our intentions. While direct electrical stimulation applied intracranially has been used for the treatment of various neurological disorders, such as Parkinson's, epilepsy, clinical depression, and Obsessive-compulsive disorder, the effectiveness can be highly variable. One perspective is that the inability to consistently treat these neurological disorders in a standardized way is due to multiple, interlaced factors, including stimulation parameters, location, and differences in underlying network connectivity, leading to a trial-and-error stimulation approach in the clinic. An alternate view, based on a growing knowledge from neural data, is that variability in this input (stimulation) and output (brain response) relationship may be more predictable and amenable to standardization, personalization, and, ultimately, therapeutic implementation. In this review, we assert that the future of human brain neurostimulation, via direct electrical stimulation, rests on deploying standardized, constrained models for easier clinical implementation and informed by intracranial data sets, such that diverse, individualized therapeutic parameters can efficiently produce similar, robust, positive outcomes for many patients closer to a prescriptive model. We address the pathway needed to arrive at this future by addressing three questions, namely: (1) why aren't we already at this prescriptive future?; (2) how do we get there?; (3) how far are we from this Neurostimulationist prescriptive future? We first posit that there are limited and predictable ways, constrained by underlying networks, for direct electrical stimulation to induce changes in the brain based on past literature. We then address how identifying underlying individual structural and functional brain connectivity which shape these standard responses enable targeted and personalized neuromodulation, bolstered through large-scale efforts, including machine learning techniques, to map and reverse engineer these input-output relationships to produce a good outcome and better identify underlying mechanisms. This understanding will not only be a major advance in enabling intelligent and informed design of neuromodulatory therapeutic tools for a wide variety of neurological diseases, but a shift in how we can predictably, and therapeutically, prescribe stimulation treatments the human brain.
Collapse
Affiliation(s)
- Peter N Hadar
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
| | - Rina Zelmann
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
- Center for Neurotechnology and Neurorecovery, Department of Neurology, Massachusetts General Hospital, Boston, MA, United States
| | - Pariya Salami
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
- Center for Neurotechnology and Neurorecovery, Department of Neurology, Massachusetts General Hospital, Boston, MA, United States
| | - Sydney S Cash
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
- Center for Neurotechnology and Neurorecovery, Department of Neurology, Massachusetts General Hospital, Boston, MA, United States
| | - Angelique C Paulk
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
- Center for Neurotechnology and Neurorecovery, Department of Neurology, Massachusetts General Hospital, Boston, MA, United States
| |
Collapse
|
26
|
Flores FJ, Dalla Betta I, Tauber J, Schreier DR, Stephen EP, Wilson MA, Brown EN. Electrographic seizures during low-current thalamic deep brain stimulation in mice. Brain Stimul 2024; 17:975-979. [PMID: 39134207 PMCID: PMC11575467 DOI: 10.1016/j.brs.2024.08.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2024] [Revised: 07/31/2024] [Accepted: 08/09/2024] [Indexed: 08/19/2024] Open
Abstract
BACKGROUND Deep brain stimulation of the central thalamus (CT-DBS) has potential for modulating states of consciousness, but it can also trigger electrographic seizures, including poly-spike-wave trains (PSWT). OBJECTIVES To report the probability of inducing PSWTs during CT-DBS in awake, freely-moving mice. METHODS Mice were implanted with electrodes to deliver unilateral and bilateral CT-DBS at different frequencies while recording electroencephalogram (EEG). We titrated stimulation current by gradually increasing it at each frequency until a PSWT appeared. Subsequent stimulations to test arousal modulation were performed at the current one step below the current that caused a PSWT during titration. RESULTS In 2.21% of the test stimulations (10 out of 12 mice), CT-DBS caused PSWTs at currents lower than the titrated current, including currents as low as 20 μA. CONCLUSION Our study found a small but significant probability of inducing PSWTs even after titration and at relatively low currents. EEG should be closely monitored for electrographic seizures when performing CT-DBS in both research and clinical settings.
Collapse
Affiliation(s)
- Francisco J Flores
- Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, 55 Fruit St, Boston, 02114, MA, USA; Center for Brains, Minds, and Machines, Massachusetts Institute of Technology, 43 Vassar St, Cambridge, 02139, MA, USA; Picower Institute for Learning and Memory, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, 43 Vassar St, Cambridge, 02139, MA, USA.
| | - Isabella Dalla Betta
- Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, 55 Fruit St, Boston, 02114, MA, USA; Picower Institute for Learning and Memory, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, 43 Vassar St, Cambridge, 02139, MA, USA.
| | - John Tauber
- Department of Mathematics and Statistics, Boston University, 665 Commonwealth Ave, Boston, 02215, MA, USA.
| | - David R Schreier
- Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, 55 Fruit St, Boston, 02114, MA, USA; Picower Institute for Learning and Memory, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, 43 Vassar St, Cambridge, 02139, MA, USA; Center for Neurotechnology and Neurorecovery, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, 101 Merrimac St, Boston, 02114, MA, USA; Department of Neurology, Inselspital, Bern University Hospital and University of Bern, Freiburgstrasse 16, Bern, 3010, Switzerland.
| | - Emily P Stephen
- Department of Mathematics and Statistics, Boston University, 665 Commonwealth Ave, Boston, 02215, MA, USA.
| | - Matthew A Wilson
- Center for Brains, Minds, and Machines, Massachusetts Institute of Technology, 43 Vassar St, Cambridge, 02139, MA, USA; Picower Institute for Learning and Memory, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, 43 Vassar St, Cambridge, 02139, MA, USA.
| | - Emery N Brown
- Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, 55 Fruit St, Boston, 02114, MA, USA; Center for Brains, Minds, and Machines, Massachusetts Institute of Technology, 43 Vassar St, Cambridge, 02139, MA, USA; Picower Institute for Learning and Memory, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, 43 Vassar St, Cambridge, 02139, MA, USA; Institute for Medical Engineering and Sciences, Massachusetts Institute of Technology, 45 Carleton St, Cambridge, 02142, MA, USA.
| |
Collapse
|
27
|
Deli A, Green AL. Deep Brain Stimulation for Consciousness Disorders; Technical and Ethical Considerations. NEUROETHICS-NETH 2024; 17:35. [PMID: 39091894 PMCID: PMC11289033 DOI: 10.1007/s12152-024-09570-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2023] [Accepted: 07/10/2024] [Indexed: 08/04/2024]
Abstract
Disorders of Consciousness (DoC) result in profound functional impairment, adversely affecting the lives of a predominantly younger patient population. Currently, effective treatment options for those who have reached chronicity (prolonged symptom duration over 4 weeks) are extremely limited, with the majority of such cases facing life-long dependence on carers and a poor quality of life. Here we briefly review the current evidence on caseload, diagnostic and management options in the United Kingdom (UK), United States of America (USA) and the European Union (EU). We identify key differences as well as similarities in these approaches across respective healthcare systems, highlighting unmet needs in this population. We subsequently present past efforts and the most recent advances in the field of surgical modulation of consciousness through implantable neurostimulation systems. We examine the ethical dilemmas that such a treatment approach may pose, proposing mediating solutions and methodological adjustments to address these concerns. Overall, we argue that there is a strong case for the utilisation of deep brain stimulation (DBS) in the DoC patient cohort. This is based on both promising results of recent clinical trials as well as technological developments. We propose a revitalization of surgical neuromodulation for DoC with a multicenter, multidisciplinary approach and strict monitoring guidelines, in order to not only advance treatment options but also ensure the safeguarding of patients' welfare and dignity.
Collapse
Affiliation(s)
- Alceste Deli
- Nuffield Department of Surgical Sciences and Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK
| | - Alexander L. Green
- Nuffield Department of Surgical Sciences and Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK
| |
Collapse
|
28
|
Vaz A, Wathen C, Miranda S, Thomas R, Darlington T, Jabarkheel R, Tomlinson S, Arena J, Bond K, Salwi S, Ajmera S, Bachschmid-Romano L, Gugger J, Sandsmark D, Diaz-Arrastia R, Schuster J, Ramayya AG, Cajigas I, Pesaran B, Chen HI, Petrov D. Return of intracranial beta oscillations and traveling waves with recovery from traumatic brain injury. BIORXIV : THE PREPRINT SERVER FOR BIOLOGY 2024:2024.07.19.604293. [PMID: 39091808 PMCID: PMC11291083 DOI: 10.1101/2024.07.19.604293] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 08/04/2024]
Abstract
Traumatic brain injury (TBI) remains a pervasive clinical problem associated with significant morbidity and mortality. However, TBI remains clinically and biophysically ill-defined, and prognosis remains difficult even with the standardization of clinical guidelines and advent of multimodality monitoring. Here we leverage a unique data set from TBI patients implanted with either intracranial strip electrodes during craniotomy or quad-lumen intracranial bolts with depth electrodes as part of routine clinical practice. By extracting spectral profiles of this data, we found that the presence of narrow-band oscillatory activity in the beta band (12-30 Hz) closely corresponds with the neurological exam as quantified with the standard Glasgow Coma Scale (GCS). Further, beta oscillations were distributed over the cortical surface as traveling waves, and the evolution of these waves corresponded to recovery from coma, consistent with the putative role of waves in perception and cognitive activity. We consequently propose that beta oscillations and traveling waves are potential biomarkers of recovery from TBI. In a broader sense, our findings suggest that emergence from coma results from recovery of thalamo-cortical interactions that coordinate cortical beta rhythms.
Collapse
Affiliation(s)
- Alex Vaz
- Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA, 19104, USA
- Surgical Neurology Branch, NINDS, National Institutes of Health, Bethesda, MD 20892, USA
| | - Connor Wathen
- Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA, 19104, USA
| | - Stephen Miranda
- Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA, 19104, USA
| | - Rachel Thomas
- Department of Neurology, University of Pennsylvania, Philadelphia, PA, 19104, USA
| | - Timothy Darlington
- Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA, 19104, USA
| | - Rashad Jabarkheel
- Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA, 19104, USA
| | - Samuel Tomlinson
- Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA, 19104, USA
| | - John Arena
- Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA, 19104, USA
| | - Kamila Bond
- Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA, 19104, USA
| | - Sanjana Salwi
- Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA, 19104, USA
| | - Sonia Ajmera
- Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA, 19104, USA
| | | | - James Gugger
- Department of Neurology, University of Pennsylvania, Philadelphia, PA, 19104, USA
| | - Danielle Sandsmark
- Department of Neurology, University of Pennsylvania, Philadelphia, PA, 19104, USA
| | - Ramon Diaz-Arrastia
- Department of Neurology, University of Pennsylvania, Philadelphia, PA, 19104, USA
| | - James Schuster
- Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA, 19104, USA
| | - Ashwin G Ramayya
- Department of Neurosurgery, Stanford University, Palo Alto, CA, 94305, USA
| | - Iahn Cajigas
- Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA, 19104, USA
| | - Bijan Pesaran
- Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA, 19104, USA
| | - H Isaac Chen
- Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA, 19104, USA
- Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA 19104, USA
| | - Dmitriy Petrov
- Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA, 19104, USA
| |
Collapse
|
29
|
Nguyen MX, Brown AM, Lin T, Sillitoe RV, Gill JS. Targeting DBS to the centrolateral thalamic nucleus improves movement in a lesion-based model of acquired cerebellar dystonia in mice. BIORXIV : THE PREPRINT SERVER FOR BIOLOGY 2024:2024.05.21.595095. [PMID: 38826430 PMCID: PMC11142135 DOI: 10.1101/2024.05.21.595095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2024]
Abstract
Dystonia is the third most common movement disorder and an incapacitating co-morbidity in a variety of neurologic conditions. Dystonia can be caused by genetic, degenerative, idiopathic, and acquired etiologies, which are hypothesized to converge on a "dystonia network" consisting of the basal ganglia, thalamus, cerebellum, and cerebral cortex. In acquired dystonia, focal lesions to subcortical areas in the network - the basal ganglia, thalamus, and cerebellum - lead to a dystonia that can be difficult to manage with canonical treatments, including deep brain stimulation (DBS). While studies in animal models have begun to parse the contribution of individual nodes in the dystonia network, how acquired injury to the cerebellar outflow tracts instigates dystonia; and how network modulation interacts with symptom latency remain as unexplored questions. Here, we present an electrolytic lesioning paradigm that bilaterally targets the cerebellar outflow tracts. We found that lesioning these tracts, at the junction of the superior cerebellar peduncles and the medial and intermediate cerebellar nuclei, resulted in acute, severe dystonia. We observed that dystonia is reduced with one hour of DBS of the centrolateral thalamic nucleus, a first order node in the network downstream of the cerebellar nuclei. In contrast, one hour of stimulation at a second order node in the short latency, disynaptic projection from the cerebellar nuclei, the striatum, did not modulate the dystonia in the short-term. Our study introduces a robust paradigm for inducing acute, severe dystonia, and demonstrates that targeted modulation based on network principles powerfully rescues motor behavior. These data inspire the identification of therapeutic targets for difficult to manage acquired dystonia.
Collapse
Affiliation(s)
- Megan X. Nguyen
- Department of Pediatrics, Division of Neurology and Developmental Neuroscience, Baylor College of Medicine, Houston, TX, USA
- Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, TX, USA
| | - Amanda M. Brown
- Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, TX, USA
- Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA
| | - Tao Lin
- Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, TX, USA
- Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA
| | - Roy V. Sillitoe
- Department of Pediatrics, Division of Neurology and Developmental Neuroscience, Baylor College of Medicine, Houston, TX, USA
- Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, TX, USA
- Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA
- Department of Neuroscience, Baylor College of Medicine, Houston, TX, USA
- Development, Disease Models & Therapeutics Graduate Program, Baylor College of Medicine, Houston, TX, USA
| | - Jason S. Gill
- Department of Pediatrics, Division of Neurology and Developmental Neuroscience, Baylor College of Medicine, Houston, TX, USA
- Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, TX, USA
| |
Collapse
|
30
|
Schiff ND. Toward an interventional science of recovery after coma. Neuron 2024; 112:1595-1610. [PMID: 38754372 PMCID: PMC11827330 DOI: 10.1016/j.neuron.2024.04.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2024] [Revised: 04/04/2024] [Accepted: 04/24/2024] [Indexed: 05/18/2024]
Abstract
Recovery of consciousness after coma remains one of the most challenging areas for accurate diagnosis and effective therapeutic engagement in the clinical neurosciences. Recovery depends on preservation of neuronal integrity and evolving changes in network function that re-establish environmental responsiveness. It typically occurs in defined steps: it begins with eye opening and unresponsiveness in a vegetative state, then limited recovery of responsiveness characterizes the minimally conscious state, and this is followed by recovery of reliable communication. This review considers several points for novel interventions, for example, in persons with cognitive motor dissociation in whom a hidden cognitive reserve is revealed. Circuit mechanisms underlying restoration of behavioral responsiveness and communication are discussed. An emerging theme is the possibility to rescue latent capacities in partially damaged human networks across time. These opportunities should be exploited for therapeutic engagement to achieve individualized solutions for restoration of communication and environmental interaction across varying levels of recovery.
Collapse
Affiliation(s)
- Nicholas D Schiff
- Jerold B. Katz Professor of Neurology and Neuroscience, Weill Cornell Medicine, New York, NY, USA.
| |
Collapse
|
31
|
Mashour GA. Anesthesia and the neurobiology of consciousness. Neuron 2024; 112:1553-1567. [PMID: 38579714 PMCID: PMC11098701 DOI: 10.1016/j.neuron.2024.03.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2024] [Revised: 03/05/2024] [Accepted: 03/06/2024] [Indexed: 04/07/2024]
Abstract
In the 19th century, the discovery of general anesthesia revolutionized medical care. In the 21st century, anesthetics have become indispensable tools to study consciousness. Here, I review key aspects of the relationship between anesthesia and the neurobiology of consciousness, including interfaces of sleep and anesthetic mechanisms, anesthesia and primary sensory processing, the effects of anesthetics on large-scale functional brain networks, and mechanisms of arousal from anesthesia. I discuss the implications of the data derived from the anesthetized state for the science of consciousness and then conclude with outstanding questions, reflections, and future directions.
Collapse
Affiliation(s)
- George A Mashour
- Center for Consciousness Science, Department of Anesthesiology, Department of Pharmacology, Neuroscience Graduate Program, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
| |
Collapse
|
32
|
Martínez-Molina N, Sanz-Perl Y, Escrichs A, Kringelbach ML, Deco G. Turbulent dynamics and whole-brain modeling: toward new clinical applications for traumatic brain injury. Front Neuroinform 2024; 18:1382372. [PMID: 38590709 PMCID: PMC10999628 DOI: 10.3389/fninf.2024.1382372] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2024] [Accepted: 03/01/2024] [Indexed: 04/10/2024] Open
Abstract
Traumatic Brain Injury (TBI) is a prevalent disorder mostly characterized by persistent impairments in cognitive function that poses a substantial burden on caregivers and the healthcare system worldwide. Crucially, severity classification is primarily based on clinical evaluations, which are non-specific and poorly predictive of long-term disability. In this Mini Review, we first provide a description of our model-free and model-based approaches within the turbulent dynamics framework as well as our vision on how they can potentially contribute to provide new neuroimaging biomarkers for TBI. In addition, we report the main findings of our recent study examining longitudinal changes in moderate-severe TBI (msTBI) patients during a one year spontaneous recovery by applying the turbulent dynamics framework (model-free approach) and the Hopf whole-brain computational model (model-based approach) combined with in silico perturbations. Given the neuroinflammatory response and heightened risk for neurodegeneration after TBI, we also offer future directions to explore the association with genomic information. Moreover, we discuss how whole-brain computational modeling may advance our understanding of the impact of structural disconnection on whole-brain dynamics after msTBI in light of our recent findings. Lastly, we suggest future avenues whereby whole-brain computational modeling may assist the identification of optimal brain targets for deep brain stimulation to promote TBI recovery.
Collapse
Affiliation(s)
- Noelia Martínez-Molina
- Computational Neuroscience Group, Center for Brain and Cognition, Department of Information and Communication Technologies, Universitat Pompeu Fabra, Barcelona, Spain
| | - Yonatan Sanz-Perl
- Computational Neuroscience Group, Center for Brain and Cognition, Department of Information and Communication Technologies, Universitat Pompeu Fabra, Barcelona, Spain
| | - Anira Escrichs
- Computational Neuroscience Group, Center for Brain and Cognition, Department of Information and Communication Technologies, Universitat Pompeu Fabra, Barcelona, Spain
| | - Morten L Kringelbach
- Centre for Eudaimonia and Human Flourishing, Linacre College, University of Oxford, Oxford, United Kingdom
- Department of Psychiatry, University of Oxford, Oxford, United Kingdom
- Department of Clinical Medicine, Center for Music in the Brain, Aarhus University and The Royal Academy of Music Aarhus/Aalborg, Aarhus, Denmark
| | - Gustavo Deco
- Computational Neuroscience Group, Center for Brain and Cognition, Department of Information and Communication Technologies, Universitat Pompeu Fabra, Barcelona, Spain
- Institució Catalana de la Recerca i Estudis Avançats, Barcelona, Spain
| |
Collapse
|
33
|
Gao C, Wu X, Wang Y, Li G, Ma L, Wang C, Xie S, Chu C, Madsen KH, Hou Z, Fan L. Prior-guided individualized thalamic parcellation based on local diffusion characteristics. Hum Brain Mapp 2024; 45:e26646. [PMID: 38433705 PMCID: PMC10910286 DOI: 10.1002/hbm.26646] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2023] [Revised: 02/10/2024] [Accepted: 02/19/2024] [Indexed: 03/05/2024] Open
Abstract
Comprising numerous subnuclei, the thalamus intricately interconnects the cortex and subcortex, orchestrating various facets of brain functions. Extracting personalized parcellation patterns for these subnuclei is crucial, as different thalamic nuclei play varying roles in cognition and serve as therapeutic targets for neuromodulation. However, accurately delineating the thalamic nuclei boundary at the individual level is challenging due to intersubject variability. In this study, we proposed a prior-guided parcellation (PG-par) method to achieve robust individualized thalamic parcellation based on a central-boundary prior. We first constructed probabilistic atlas of thalamic nuclei using high-quality diffusion MRI datasets based on the local diffusion characteristics. Subsequently, high-probability voxels in the probabilistic atlas were utilized as prior guidance to train unique multiple classification models for each subject based on a multilayer perceptron. Finally, we employed the trained model to predict the parcellation labels for thalamic voxels and construct individualized thalamic parcellation. Through a test-retest assessment, the proposed prior-guided individualized thalamic parcellation exhibited excellent reproducibility and the capacity to detect individual variability. Compared with group atlas registration and individual clustering parcellation, the proposed PG-par demonstrated superior parcellation performance under different scanning protocols and clinic settings. Furthermore, the prior-guided individualized parcellation exhibited better correspondence with the histological staining atlas. The proposed prior-guided individualized thalamic parcellation method contributes to the personalized modeling of brain parcellation.
Collapse
Affiliation(s)
- Chaohong Gao
- Sino‐Danish CollegeSino‐Danish Center for Education and ResearchUniversity of Chinese Academy of SciencesBeijingChina
- Brainnetome Center, Institute of AutomationChinese Academy of SciencesBeijingChina
- Department of Applied Mathematics and Computer ScienceTechnical University of DenmarkKongens LyngbyDenmark
| | - Xia Wu
- Brainnetome Center, Institute of AutomationChinese Academy of SciencesBeijingChina
| | - Yaping Wang
- Sino‐Danish CollegeSino‐Danish Center for Education and ResearchUniversity of Chinese Academy of SciencesBeijingChina
- Brainnetome Center, Institute of AutomationChinese Academy of SciencesBeijingChina
- Department of Applied Mathematics and Computer ScienceTechnical University of DenmarkKongens LyngbyDenmark
| | - Gang Li
- Brainnetome Center, Institute of AutomationChinese Academy of SciencesBeijingChina
| | - Liang Ma
- Brainnetome Center, Institute of AutomationChinese Academy of SciencesBeijingChina
| | - Changshuo Wang
- Sino‐Danish CollegeSino‐Danish Center for Education and ResearchUniversity of Chinese Academy of SciencesBeijingChina
- Brainnetome Center, Institute of AutomationChinese Academy of SciencesBeijingChina
| | - Sangma Xie
- Institute of Biomedical Engineering and Instrumentation, School of AutomationHangzhou Dianzi UniversityHangzhouChina
| | - Congying Chu
- Brainnetome Center, Institute of AutomationChinese Academy of SciencesBeijingChina
| | - Kristoffer Hougaard Madsen
- Sino‐Danish CollegeSino‐Danish Center for Education and ResearchUniversity of Chinese Academy of SciencesBeijingChina
- Department of Applied Mathematics and Computer ScienceTechnical University of DenmarkKongens LyngbyDenmark
- Danish Research Centre for Magnetic Resonance, Centre for Functional and Diagnostic Imaging and ResearchCopenhagen University Hospital—Amager and HvidovreHvidovreDenmark
| | - Zhongyu Hou
- Department of Medical ImagingShandong Provincial Hospital Affiliated to Shandong First Medical UniversityJinanChina
| | - Lingzhong Fan
- Sino‐Danish CollegeSino‐Danish Center for Education and ResearchUniversity of Chinese Academy of SciencesBeijingChina
- Brainnetome Center, Institute of AutomationChinese Academy of SciencesBeijingChina
- CAS Center for Excellence in Brain Science and Intelligence Technology, Institute of AutomationChinese Academy of SciencesBeijingChina
- School of Health and Life SciencesUniversity of Health and Rehabilitation SciencesQingdaoShandongChina
| |
Collapse
|
34
|
Ferrero JJ, Hassan AR, Yu Z, Zhao Z, Ma L, Wu C, Shao S, Kawano T, Engel J, Doyle W, Devinsky O, Khodagholy D, Gelinas JN. Closed-loop electrical stimulation to prevent focal epilepsy progression and long-term memory impairment. BIORXIV : THE PREPRINT SERVER FOR BIOLOGY 2024:2024.02.09.579660. [PMID: 38405990 PMCID: PMC10888806 DOI: 10.1101/2024.02.09.579660] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/27/2024]
Abstract
Interictal epileptiform discharges (IEDs) are ubiquitously expressed in epileptic networks and disrupt cognitive functions. It is unclear whether addressing IED-induced dysfunction could improve epilepsy outcomes as most therapeutics target seizures. We show in a model of progressive hippocampal epilepsy that IEDs produce pathological oscillatory coupling which is associated with prolonged, hypersynchronous neural spiking in synaptically connected cortex and expands the brain territory capable of generating IEDs. A similar relationship between IED-mediated oscillatory coupling and temporal organization of IEDs across brain regions was identified in human subjects with refractory focal epilepsy. Spatiotemporally targeted closed-loop electrical stimulation triggered on hippocampal IED occurrence eliminated the abnormal cortical activity patterns, preventing spread of the epileptic network and ameliorating long-term spatial memory deficits in rodents. These findings suggest that stimulation-based network interventions that normalize interictal dynamics may be an effective treatment of epilepsy and its comorbidities, with a low barrier to clinical translation. One-Sentence Summary Targeted closed-loop electrical stimulation prevents spread of the epileptic network and ameliorates long-term spatial memory deficits.
Collapse
|
35
|
Huang Z, Mashour GA, Hudetz AG. Propofol Disrupts the Functional Core-Matrix Architecture of the Thalamus in Humans. BIORXIV : THE PREPRINT SERVER FOR BIOLOGY 2024:2024.01.23.576934. [PMID: 38328136 PMCID: PMC10849566 DOI: 10.1101/2024.01.23.576934] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/09/2024]
Abstract
Research into the role of thalamocortical circuits in anesthesia-induced unconsciousness is difficult due to anatomical and functional complexity. Prior neuroimaging studies have examined either the thalamus as a whole or focused on specific subregions, overlooking the distinct neuronal subtypes like core and matrix cells. We conducted a study of heathy volunteers and functional magnetic resonance imaging during conscious baseline, deep sedation, and recovery. We advanced the functional gradient mapping technique to delineate the functional geometry of thalamocortical circuits, within a framework of the unimodal-transmodal functional axis of the cortex. We observed a significant shift in this geometry during unconsciousness, marked by the dominance of unimodal over transmodal geometry. This alteration was closely linked to the spatial variations in the density of matrix cells within the thalamus. This research bridges cellular and systems-level understanding, highlighting the crucial role of thalamic core-matrix functional architecture in understanding the neural mechanisms of states of consciousness.
Collapse
Affiliation(s)
- Zirui Huang
- Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
- Center for Consciousness Science, University of Michigan Medical School, Ann Arbor, MI 48109, USA
- Michigan Psychedelic Center, University of Michigan Medical School, Ann Arbor, MI, 48109, USA
- Neuroscience Graduate Program, University of Michigan, Ann Arbor, MI 48109, USA
| | - George A Mashour
- Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
- Center for Consciousness Science, University of Michigan Medical School, Ann Arbor, MI 48109, USA
- Michigan Psychedelic Center, University of Michigan Medical School, Ann Arbor, MI, 48109, USA
- Neuroscience Graduate Program, University of Michigan, Ann Arbor, MI 48109, USA
- Department of Pharmacology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA
| | - Anthony G Hudetz
- Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
- Center for Consciousness Science, University of Michigan Medical School, Ann Arbor, MI 48109, USA
- Michigan Psychedelic Center, University of Michigan Medical School, Ann Arbor, MI, 48109, USA
- Neuroscience Graduate Program, University of Michigan, Ann Arbor, MI 48109, USA
| |
Collapse
|
36
|
Fins JJ, Merner AR, Wright MS, Lázaro-Muñoz G. Identity Theft, Deep Brain Stimulation, and the Primacy of Post-trial Obligations. Hastings Cent Rep 2024; 54:34-41. [PMID: 38390681 PMCID: PMC11022755 DOI: 10.1002/hast.1567] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/24/2024]
Abstract
Patient narratives from two investigational deep brain stimulation trials for traumatic brain injury and obsessive-compulsive disorder reveal that injury and illness rob individuals of personal identity and that neuromodulation can restore it. The early success of these interventions makes a compelling case for continued post-trial access to these technologies. Given the centrality of personal identity to respect for persons, a failure to provide continued access can be understood to represent a metaphorical identity theft. Such a loss recapitulates the pain of an individual's initial injury or illness and becomes especially tragic because it could be prevented by robust policy. A failure to fulfill this normative obligation constitutes a breach of disability law, which would view post-trial access as a means to achieve social reintegration through this neurotechnological accommodation.
Collapse
|
37
|
Pease M, Arefan D, Hammond FM, Castellano JF, Okonkwo DO, Wu S. Computational Prognostic Modeling in Traumatic Brain Injury. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 2024; 1462:475-486. [PMID: 39523284 DOI: 10.1007/978-3-031-64892-2_29] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/16/2024]
Abstract
Traumatic brain injury is the leading cause of death and disability worldwide. Despite this large impact, no predictive models are in widespread use due to tedious data collection requirements, lack of provider trust, and poor performance. Furthermore, these models use simple, often binary, data elements that fail to capture the complex heterogeneity of traumatic brain injury. Recent advances in computational modeling efforts have demonstrated promising results for capturing imaging, clinical, electroencephalographic, and other biomarkers for powerful predictive models. In this review, we provide an overview of efforts in computational modeling in neurotrauma and provide insights into future directions.
Collapse
Affiliation(s)
- Matthew Pease
- Department of Neurosurgery, Indiana University, Indianapolis, IN, USA
| | - Dooman Arefan
- Department of Radiology, University of Pittsburgh, Pittsburgh, PA, USA
| | - Flora M Hammond
- Department of Physical Medicine & Rehabilitation, Indiana University, Indianapolis, IN, USA
| | | | - David O Okonkwo
- Department of Neurosurgery, University of Pittsburgh, Pittsburgh, PA, USA
| | - Shandong Wu
- Department of Radiology, University of Pittsburgh, Pittsburgh, PA, USA.
- Department of Biomedical Informatics; Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA.
| |
Collapse
|